David Dreman

Research completed 2026-07-20. This is a historical reconstruction, not a description of a current product: Dreman Value Management's SEC registration ended in 2018, and no current Dreman-managed public mandate was verified. “Dreman” below means his documented personal teaching; “DVM” means the team and regulated process at the date of the cited source. (SEC/IAPD, accessed 2026-07-20)

Core worldview

David Dreman's starting proposition was that markets are competitive but not perfectly efficient because investors repeatedly make the same psychological errors. People extrapolate recent success, treat uncertain forecasts as precise, crowd into companies with a clear and exciting story, and abandon businesses associated with disappointment. Price therefore embeds not just information, but an asymmetry of expectations: popular stocks have little room for favorable surprise and much room for disappointment; unpopular stocks face the reverse. Dreman and Michael Berry's study of 66,100 analyst consensus estimates [single-source] found large forecast errors that did not disappear by business cycle or industry, directly challenging finely calibrated earnings-based valuation. (CFA Institute, 1995)

The investable translation was deliberately simple. Low price-to-earnings was the primary signal of pessimism; low price-to-book, low price-to-cash-flow and high dividend yield were corroborating measures. His 1996 description placed the focus in roughly the bottom fifth of market P/Es, but the principle was relative cheapness rather than one permanent numerical cutoff [single-source]. The firm later formalized comparisons to a company's own history and to homogeneous industry peers. (Los Angeles Times, 1996; DVM Form ADV brochure, 2014)

This was probabilistic, not prophetic. A low multiple did not prove that one stock was mispriced, and Dreman repeatedly acknowledged long stretches of underperformance. The claim was that a diversified set of financially sound, out-of-favor businesses offered favorable base rates because expectations were easier to exceed. His and Eric Lufkin's paper reported that favored and unfavored stocks experienced large return differences without comparably large movements in underlying fundamentals; the authors interpreted the gap as psychological overreaction. That interpretation is evidence for the worldview, not a settled causal fact. (Dreman and Lufkin, 2000)

The edge — expectations, rules and institutional discomfort

Dreman believed the first edge was expectations arbitrage. Analysts and investors are overconfident about glamour companies, so a small miss can cause a disproportionate fall; they are excessively pessimistic about low-multiple companies, so merely adequate results can re-rate the stock. His research on asymmetric reactions to earnings surprises made that mechanism more specific than “buy what everyone hates.” (Dreman, 1995; Dreman and Berry, 1995)

The second edge was behavioral endurance. A cheap security is normally attached to an unpleasant story, so holding it creates career, client and emotional pressure. Dreman's rules externalized the decision: screen before storytelling, demand financial staying power, diversify the inevitable errors, and sell on defined conditions. In his 2012 interview, he said that understanding the rule was easy while carrying it out against emotional pressure was hard. (Morningstar, 2012)

The third was institutional neglect. A 2006 regulated description treated low or sharply declining institutional ownership as evidence that a stock was falling out of Wall Street favor. Yet Dreman was not claiming private information: he stressed that lists of cheap and expensive stocks were readily available. The edge had to come from disciplined interpretation and willingness to act, not exclusive data. (American Skandia Trust prospectus, 2006)

Independent research lends support but not exclusivity to this explanation. Lakonishok, Shleifer and Vishny attributed value returns to investor extrapolation rather than greater fundamental risk, while Lu Zhang later modeled value firms as riskier, especially in bad states when their costly assets are hard to shed. Dreman's psychological account is therefore one plausible explanation of the value premium, not proof that all of it is mispricing or that the premium is free of crash risk. (Lakonishok, Shleifer and Vishny, 1994; Zhang, 2005)

Process

1. Idea sourcing

The mature institutional funnel began with the investable market-capitalization range for the mandate. DVM grouped candidates by sector and industry, removed above-market valuations using P/E, P/B and P/CF, then compared the survivors with their own histories and peers. By 2014 that process typically produced three or four candidates in each category for fundamental review [single-source]. (DVM Form ADV brochure, 2014)

Earlier disclosures show the hierarchy more plainly: low P/E first, then P/B and P/CF, with high yield and declining institutional ownership as supporting evidence. A 2009 small-cap prospectus described daily multifactor rankings, the lowest P/E quintile, secondary value screens, bottom-up research, and investment-committee approval. These are product- and date-specific versions of the process, not one timeless mechanical formula. (American Skandia Trust prospectus, 2006; Sun Capital/Dreman Small Cap Value prospectus, 2009)

Negative surprises and panics were also sources. In 2002, the team bought small positions in energy traders pulled down with Enron and added to weak pharmaceutical stocks, explicitly distinguishing company-specific impairment from indiscriminate fear. The report also shows the danger: judgments that one company is merely “dragged down” can be wrong. (Scudder shareholder report, 2002)

2. Research: reject deserved cheapness

The screen generated hypotheses; it did not authorize purchase. Dreman warned in a regulated filing that mere cheapness seldom produces superior results without needless risk. Analysts examined earnings power, balance-sheet liquidity, cash and current ratios, debt capacity, competitive position and dividend durability. One 2006 mandate set a goal of no more than 50%–60% debt to total capital [single-source, mandate-specific] and generally rejected weak companies and bankruptcy speculation except in special circumstances. (American Skandia Trust prospectus, 2006)

Earnings had to be both real and capable of normalization. In 1996, Dreman said he sought low-P/E companies with earnings rising faster than the market; a 2008 mid-cap prospectus similarly required financial soundness plus prospects for appreciation and dividend growth. The 2014 team process asked whether depressed earnings power was temporary or structural. (Los Angeles Times, 1996; AFBA 5Star prospectus, 2008; DVM Form ADV brochure, 2014)

After the financial crisis, the filter hardened. Dreman said that a company reporting a loss should be sold and reconsidered only after profitability returned; he also warned that bank and insurer losses could be too opaque to locate. In a 2010 postmortem he said the process should exit more quickly when earnings became indeterminate. That was an explicit process repair, not a rule demonstrably followed before 2008. (GuruFocus interview, 2010; Forbes interview, 2012; Forbes/GuruFocus interview, 2015)

3. Valuation and entry

Dreman did not rely on a finely tuned point estimate of intrinsic value—the forecast error he documented made that precision suspect. Entry instead required a substantial multiple discount to the market, the company's history, or industry peers, accompanied by evidence that the denominator was not fictitious. The 2012 book review describes an industry-relative variant: buy the cheapest qualifying stocks within each industry, improving diversification compared with simply owning the market's lowest P/Es. (CFA Institute, 1995; Loughran, 2012)

This leaves entry intentionally imprecise. The sources disclose rankings and relative cutoffs, but not a universal discount rate, margin-of-safety percentage or DCF hurdle. A price fall on bad news was an opportunity only after the team classified the damage as temporary. “Contrarian” therefore described the source of the discount; fundamental work determined whether it was investable.

4. Sizing

Diversification, not concentrated conviction, was the primary stated position-level defense. Dreman described roughly 50–60 stocks, approximately equal initial purchases and a one-in/one-out replacement rule in a 2012 interview [single-source]; he separately recommended at least 100 equally weighted names for an individual implementing a more mechanical strategy [single-source]. Those are different portfolios and should not be collapsed into a single rule. No reliable public source located a universal maximum initial position, add rule or individual-name stop-loss for DVM's institutional mandates. (Forbes interview, 2012; Morningstar, 2012)

Equal or near-equal weighting expresses an important belief: forecasts about any one unpopular company are too fallible to justify a heroic bet. It also means the expected payoff came from the distribution of surprises across a basket, not from knowing precisely which security would recover.

5. Portfolio construction

The desired portfolio spread errors across companies and industries while preserving a common low-expectations exposure. Industry-relative ranking was an answer to the natural sector crowding of an absolute low-P/E screen. Dividend yield added current return and, in Dreman's theory, a cushion in weak markets; one 2006 mandate targeted portfolio yield at least 0.5 percentage point above the S&P 500 [single-source, mandate-specific]. That target was a disclosed aspiration, not proof of downside protection. (American Skandia Trust prospectus, 2006)

Actual portfolios could still be clustered. The 2002 variable portfolio identified financials, tobacco, energy and health care as core concentrations. In early 2009, approximately 21% of the terminated flagship was in financials [single-source]. Many names do not eliminate sector, factor, liquidity or common-denominator risk. (Scudder shareholder report, 2002; Institutional Investor, 2011)

Nor were all actual holdings close to equal weight. At 2003-11-30, the flagship's ten largest equity positions were 47.6% of the portfolio, Altria alone was 9.8%, and financials and consumer staples were 31% and 23% of equities, respectively [single-source, one date]. The audited report called sector weights residual outcomes of bottom-up stock selection. Later equal-weight recommendations therefore describe an evolution, an ideal, or a different product—not the historical flagship at every date. (Scudder-Dreman audited shareholder report, 2003)

6. Sell discipline

The original valuation exit was clear: sell when a low-multiple stock approaches the market multiple and recycle into a cheaper candidate, regardless of how attractive the story has become. By 2004, the practice had evolved from immediate sale to completing the exit over roughly six to eight months to capture some continuing momentum [single-source]. That modification is revealing: the philosophy was rule-bound but empirical, not dogmatic. (Los Angeles Times, 1996; Motley Fool interview, 2004)

There were two override rules. First, sell after roughly three years if the thesis has not worked, even when the company still looks attractive on paper; Dreman presented this as protection against attachment and stale value traps. Second, sell immediately when unexpected bad news materially impairs the future, rather than reacting to an ordinary weak quarter. The three-year discipline appears consistently in 1996, 2004 and 2015 interviews. (Los Angeles Times, 1996; Motley Fool interview, 2004; Forbes/GuruFocus interview, 2015)

Risk management

By 2014 DVM defined “true risk” as permanent capital loss over an appropriate horizon, not volatility, and divided it into three controls: do not overpay; distinguish temporary from structural earnings impairment; and require a balance sheet able to survive volatility. The firm also disclosed that value could stay unrecognized for extended periods and that small-cap, international and liquidity risks remained. This is the later team formulation, not a verbatim rule from Dreman's 1977 book. (DVM Form ADV brochure, 2014)

At the portfolio level, risk control meant many names, cross-industry diversification, financial-strength filters, dividends and explicit exits. No universal institutional price-stop rule was located; the documented sell controls instead responded to valuation, time and fundamental impairment, while a price fall could create opportunity. Nor did those controls guarantee capital preservation. The flagship Class A lost 45.50% in calendar 2008 [single-source], while a related but distinct DWS variable portfolio reported -48.81% in its 2008 performance table [single-source]. (Motley Fool interview, 2004; Plan return filing, 2009; DWS annual report, 2009)

Temperament and psychology

Dreman's required temperament combined skepticism with humility. Investors had to distrust vivid narratives and precise forecasts, accept looking wrong for years, and use rules because intuition becomes least reliable under social pressure. He called gut instinct a portfolio graveyard and preferred statistical base rates. Yet humility also required admitting that some cheap stocks were correctly priced and that no sell rule was perfect. (Morningstar, 2012)

His own origin story reinforced this stance: after participating in the late-1960s glamour boom and suffering large losses, he rebuilt around value and crowd psychology. The earlier 1996 account supports the episode's direction, although later interviews give more dramatic personal-loss estimates that remain retrospective. (Los Angeles Times, 1996; Forbes/GuruFocus interview, 2015)

Evolution over the career

• 1977–1982 — psychology becomes a strategy. Psychology and the Stock Market established the behavioral lens; the first Contrarian Investment Strategy—cataloged as 1979 by Google Books but dated 1980 in later DVM materials—and its 1982 revision expanded the rules and instruments. Bibliographic records establish the sequence, not that every later rule appeared in the first edition. (WorldCat, 1977; Google Books, 1979; DVM Form ADV brochure, 2014; WorldCat, 1982)
• 1990s — the intuition becomes testable. The forecast-error and earnings-surprise studies gave the behavioral explanation measurable predictions; the 1998 book consolidated value research, bias analysis and Dreman's stock-selection criteria. (CFA Institute, 1995; CFA Institute book review, 1998)
• 2000s — institutional scale and product breadth. Screens, analysts and investment-committee approval turned an author's framework into a team process. DVM also contemplated long/short products that would apply overvaluation screens to expensive stocks, a broader toolkit than the classic long-only fund. (Institutional Investor, 2007; Sun Capital/Dreman prospectus, 2009)
• Post-2008 — explicit repair. Dreman said the process should exit more quickly when earnings became indeterminate, then emphasized no-loss screens, heavier diversification and caution toward opaque financial-company leverage. The 2012 revision reframed risk after the crisis, while CIO authority passed to E. Clifton Hoover in 2010. Later DVM process descriptions therefore combine Dreman's philosophy with team learning and succession. (GuruFocus interview, 2010; Forbes interview, 2012; Simon & Schuster, 2012; DVM succession announcement, 2010)

What he explicitly rejected

Dreman rejected efficient-market theory as a complete description of prices, finely calibrated analyst forecasts, story-first glamour investing, gut instinct, and buying a concept or fad at any price. He also rejected pure statistical cheapness without financial strength, weak-company speculation except in special cases, and indefinite loyalty to a failed holding. His 2012 book further warned against new, complex investment-bank products whose leverage or liquidity could be misunderstood. (DVM Form ADV brochure, 2014; American Skandia Trust prospectus, 2006; Loughran, 2012)

He did not reject indexing for everyone. He said indexing was sensible for most investors because few active managers outperform over a decade; his disagreement with efficient-market advocates concerned why active managers fail. That is an unusually important boundary: belief in exploitable mispricing did not imply that every investor possessed the temperament or process to exploit it. (Morningstar, 2012)

Regimes where it thrives versus struggles

Tensions between stated philosophy and actual behavior

1. Downside protection versus the realized drawdown. A 2006 mandate sought to protect capital in downturns and called dividends defensive; the 2008 flagship result was -45.50% [single-source]. Low price and yield did not offset a collapsing earnings denominator. (American Skandia Trust prospectus, 2006; Plan return filing, 2009)
2. Strong balance sheets versus hidden leverage. The process explicitly tested debt, cash and self-financing capacity, yet Dreman later acknowledged that neither his team nor the banks understood the depth of real-estate exposure. The failure was not absence of a rule but inability of published accounts and analysis to measure what the rule required. (Institutional Investor, 2011; Morningstar, 2014)
3. Bad-news exits versus persistence in banks. Dreman's documented rule required immediate sale on thesis-breaking news, but he retained financials through the crisis and defended survivors. The post-crisis no-loss rule implicitly concedes that the earlier judgment threshold was too permissive. (Motley Fool interview, 2004; New York Times, 2009; Forbes interview, 2012)
4. Equal-weight doctrine versus actual concentration. Many holdings reduce single-company surprise risk, but the 2003 flagship's top ten represented 47.6% and Altria alone 9.8% [single-source, one date]; absolute cheapness also crowded portfolios into common sectors. Industry-relative selection and later equal-weight guidance were genuine improvements, not faithful descriptions of every earlier portfolio. (Scudder-Dreman audited shareholder report, 2003; Loughran, 2012)
5. Permanent-loss risk versus client-path risk. Calling volatility “not true risk” is coherent for patient capital, but mutual-fund sponsors and redeeming clients make the path economically real. DWS replaced DVM near the 2009 trough; a separate fund Dreman then managed reportedly rebounded [single-source], yet that did not restore the terminated mandate. A philosophy must survive governance and liquidity, not merely be right eventually. (New York Times, 2009; Institutional Investor, 2011)
6. Behavioral alpha versus compensated risk. Dreman's research makes a serious case for overreaction, but alternative asset-pricing work links value returns to distress and bad-state exposure. His results cannot by themselves identify how much came from psychology, factor risk, sector selection, scale or luck. (Dreman and Lufkin, 2000; Zhang, 2005)
7. Founder doctrine versus team implementation. The 2014 brochure preserved Dreman's language, but Hoover and Nelson Woodard held CIO authority and the team chose among screened candidates. Later process statements should not be treated as Dreman's unchanged personal checklist. (DVM Form ADV brochure, 2014; DVM succession announcement, 2010)

The durable lesson is narrower than “be contrarian.” Dreman built a repeatable way to purchase low expectations while acknowledging forecast error: start with valuation, demand survivable fundamentals, diversify, pre-commit to exits, and accept uncomfortable holding periods. The 2008 failure adds the missing clause: when earnings and balance sheets cannot be observed reliably, statistical cheapness is not a margin of safety.

Evidence boundary and verdict

David Dreman did not publish a personal transaction ledger or a verified lifetime composite. The strongest record is therefore the audited shareholder reporting for the Scudder-Dreman High Return Equity Fund (the flagship) plus contemporaneous reporting about Dreman Value Management (DVM). Those are team-managed, vehicle-specific results—not proof that Dreman alone selected every security. Values below are period-end market values unless a source explicitly identifies cost or realized gain. “Return unknown” means precisely that: a price rise or a larger holding value is not converted into a trade return without purchase, sale and cash-flow data.

Dreman’s retrospective “best investment” answer named the tobacco group—Philip Morris and R.J. Reynolds—not a single closed lot. There is no defensible lifetime winner by realized dollars. Under a transparent, reproducible rule, this report designates Ryanair as the single best completed trade with disclosed cash-flow terms because average entry, dividend entitlement and exit are available. Philip Morris/Altria is the largest best-documented open campaign; UST is the strongest long-duration corporate-action case, but the fund’s final holding-through-close is unverified.

1. UST — the strongest long-duration corporate-action case

Context, thesis and dates. UST was a longstanding smokeless-tobacco holding. In 2004, sales growth and higher prices lifted earnings beyond estimates while market share held even as competitors discounted. That operating strength coexisted with serious adverse evidence: UST recorded a $280 million pretax antitrust-resolution charge, including cash and transfer of its cigar business to Swedish Match. The rerating can therefore be read partly as legal-overhang relief, not just pricing-power recognition (2004 audited fund report; Swedish Match settlement announcement; UST 2004 annual report).

Size, path, exit and P&L. The flagship held 5,754,300 shares worth $207.097 million at November 2003, 4.3% of its investment portfolio. It reported periodic sales during 2004, but net shares actually rose to 5,828,600, so “profit-taking” did not then mean net de-risking. The position was 5,364,330 shares worth $310.595 million by November 2007, then 1,070,884 shares worth $73.623 million by November 2008 after extensive later trimming. Altria closed the acquisition on January 6, 2009 for $69.50 cash per share. That price was 93.1% above the $35.99 audited November 2003 mark, excluding dividends; it is a mark-to-terminal-price comparison, not fund cost-basis return, and the record does not confirm that the final shares were held through closing. No exact campaign drawdown was disclosed (2003, 2007 and 2008 audited reports; Altria closing announcement).

Lesson. Pricing power, dividends, legal-overhang resolution and staged realization all mattered. The cash acquisition supplies an objective issuer endpoint, but only tax-lot records could establish whether the fund completed at that price and what the campaign returned.

2. Philip Morris / Altria — the largest open component of Dreman’s best theme

Context, dates and discovery. DVM first bought Philip Morris (renamed Altria in 2003) in 2000, when litigation risk and ethical exclusions made tobacco deeply unpopular. Dreman’s March 2003 public analysis separated Kraft and international tobacco from the US cigarette business and estimated that the tobacco component could be bought for less than five times earnings. This is a textbook application of his low-multiple screen followed by event-risk analysis, not a generic “sin stock” story (Dreman in Forbes, 2003; Washington Post/Bloomberg, 2005).

Size and structure. A December 2005 report says DVM added near $20 in 2003, but that firmwide single-source figure conflicts with the unadjusted flagship marks and may reflect a different basis or vehicle; it is not used for return arithmetic. At November 30, 2003 the flagship held 9,001,175 shares worth $468.061 million, or 9.8% of market value; a year later it held 9,608,875 shares worth $552.414 million, or 9.4%. The same 2005 report said DVM held about 14.6 million shares firm-wide after trimming 2.5 million in the prior quarter. The firm-wide count must not be spliced into the flagship series (2003 audited report; 2004 audited report; Wall Street Journal reprint, 2005).

Path, drawdown and catalyst. The stock fell sharply in March 2003 after an Illinois court awarded more than $10 billion in a light-cigarette class action; DVM held and added, although no exact flagship drawdown was disclosed. It rebounded after the appeal bond was reduced and a Florida $145 billion class-action verdict was dismissed. The next major rerating came when a federal appeals court disallowed the government’s proposed $280 billion disgorgement remedy in February 2005 (2003 audited report; Los Angeles Times on the Florida dismissal; US Department of Justice petition). That remedy ruling was not an exoneration: DOJ later won RICO liability, and says a 2022 corrective-statements order resolved the historic federal litigation. The later endpoint is not credited to the 2005 result (DOJ case history; DOJ, 2022).

Exit and P&L. By February 2005 the shares had more than doubled from DVM’s first purchase and traded at $66.20; by December, reporting attributed roughly $300 million of 2005 appreciation to DVM’s Altria holding. Both figures are contemporaneous but each is a single-source description, not audited realized P&L. No complete flagship exit or lifetime total return was found. Dreman later identified Philip Morris and R.J. Reynolds jointly as his best investment, but that recollection is preserved as retrospective evidence, not used to calculate a return (Washington Post/Bloomberg, 2005; Wall Street Journal reprint, 2005; retrospective interview republication).

Lesson. The edge was willingness to underwrite a bounded legal question that other investors treated as unquantifiable. Skill showed in the valuation, legal work and repeated buying; luck mattered because discrete appellate rulings could have gone the other way. The concentration also demonstrates that DVM’s actual portfolios could depart materially from Dreman’s later equal-weight teaching.

3. Ryanair — the single best completed trade with disclosed cash-flow terms

Context, thesis and dates. DVM began buying the Irish low-cost airline in May 2010 after Iceland’s volcanic eruption grounded flights and compressed the stock from about 20 times projected earnings to 12 times. The thesis was a temporary operational shock, not a permanent deterioration in the carrier’s economics. This was a DVM team decision during the 2010 CIO transition: the contemporary account quotes incoming CIO E. Clifton Hoover, so it should not be represented as Dreman’s solitary trade (Institutional Investor, 2011).

Size, path, exit and P&L. DVM paid an average $25.20 and sold in September at $31.18 after becoming entitled to a $1.81 special cash dividend. The retrospective account says “after receiving,” but Ryanair’s official timetable placed the record date on September 17 and cash payment in October; the chronology is consistent only with an ex-dividend September sale and later receipt. No share count, vehicle, portfolio weight, exact trade dates or interim drawdown is disclosed. On the stated cash flows, the reconstructed gross return is 30.9%: ($31.18 + $1.81) / $25.20 - 1. It may overstate net return because it excludes withholding tax, ADR fees, foreign exchange, other taxes and trading costs (Institutional Investor, 2011; Ryanair dividend timetable).

Lesson. A temporary headline can create a contrarian opportunity without requiring a heroic long-duration forecast. Ryanair is unusually useful because entry, dividend and sale are all disclosed; the missing vehicle and size still prevent translating the percentage into firm profit.

4. Humana — the best audited realized-gain evidence

Context, thesis and dates. A 1998 contemporaneous report identifies Dreman as a buyer of “battered” Humana, although it does not prove the flagship’s lot date; a related Dreman variable portfolio owned it by June 2002. In the flagship’s 2003 fiscal year, DVM described the insurer as a healthcare bright spot: tighter operating-cost control was translating into higher earnings. Humana’s own filing corroborates the mechanism—2003 revenue rose to $12.226 billion from $11.261 billion, while pricing above medical-cost inflation and overhead leverage improved results. The service-center consolidation was not free: it also produced impairment and accelerated-depreciation charges (Los Angeles Times, 1998; 2002 shareholder report; 2003 audited flagship report; Humana 2003 Form 10-K).

Size, path, exit and P&L. The flagship ended November 2003 with 1,495,600 shares worth $33.397 million, about 0.7% of its $4.777 billion investment portfolio (calculated). Its affiliated-issuer table reports $30.929 million cost for shares sold during the fiscal year and a $13.164 million realized gain. That equals 42.6% on the disposed cost by arithmetic, excluding dividends and the unsold position; it is not a lifetime trade return. Humana was absent by November 2004, establishing completion during fiscal 2004 but not the final sale price, total profit or maximum drawdown (2003 and 2004 audited reports).

Lesson. This is the cleanest proof that DVM monetized a rerating rather than merely marking up an ending holding. It also shows why realized-gain tables are superior to reconstructed price charts: they preserve the actual fund lot economics, though only for the disclosed sales.

5. R.J. Reynolds / Reynolds American — the completed leg of Dreman’s best theme

Context, thesis and dates. The flagship held R.J. Reynolds by November 2000. Dreman’s tobacco thesis was that investors extrapolated enormous punitive awards while underweighting appellate precedent, cash generation and dividends. Litigation-risk compression helped in 2003; the July 2004 Brown & Williamson combination then supplied cost and sales catalysts. The FTC allowed that merger after finding it unlikely to create or enhance market power (2000 audited report; Reynolds combination announcement; FTC decision; 2004 audited report).

Size, path, exit and P&L. The flagship held 2,908,331 R.J. Reynolds shares worth $160.540 million, or 3.4% of the portfolio, at November 2003. The merger converted RJR shares one-for-one; 2,119,641 Reynolds American shares remained in 2004, a 27.1% net reduction, although gross purchases and sales are unknown. The 2005 holding was 1,601,441 shares worth $142.560 million. The 2004 report says DVM reduced near full value and took profits; the 2006 report says the remaining position was sold entirely “at a significant profit.” Reynolds also assumed Brown & Williamson’s historic and future US tobacco-litigation liabilities, so the combination did not eliminate the core risk. No tax-lot cost, proceeds, full return or maximum drawdown was disclosed (Reynolds closing filing; 2003, 2004, 2005 and 2006 audited reports).

Lesson. This is the clean closed component of the broader tobacco winner. It combines a legally informed variant view with a corporate catalyst and shows staged selling as the discount disappeared.

6. Transocean — deepwater recovery and staged realization

Context, thesis and dates. The flagship held Transocean by November 2003. In 2004, high oil prices, scarcity of deepwater capacity and rising exploration demand drove the rerating; DVM called Transocean the fund’s top performer. The trade had a real capacity thesis, but the oil-price surge was also a strong macro tailwind (2003 and 2004 audited reports; Transocean contract announcement).

Size, path, exit and P&L. Holdings moved from 1,442,075 shares worth $27.947 million at November 2003 ($19.38 per share) to 1,461,175 worth $58.842 million in 2004 ($40.27), then fell to 251,875 shares worth $16.080 million in 2005 ($63.84). The audited marks rose 229.4% from 2003 to 2005 while DVM cut the share count 82.8% from its 2004 level; the position was absent in 2006. Those are mark-to-mark and position-change calculations, not realized return. Cost basis, dividends, execution prices and absolute profit remain unknown (2003, 2004, 2005 and 2006 audited reports).

Lesson. The best cyclical trades combine depressed valuation with an observable capacity constraint, then realize gains in stages. One should not relabel the commodity beta as pure security-selection alpha.

7. Kerr-McGee — tender-driven realization

Context, thesis and dates. The flagship owned Kerr-McGee by November 2002 as part of its contrarian energy exposure. In 2005, activist pressure and a large issuer self-tender supplied a concrete value-realization mechanism. Kerr-McGee bought 46.7 million shares for about $4 billion at $85 each; DVM tendered shares and reported a significant gain (2002 audited report; 2005 audited report; Kerr-McGee 2005 annual report).

Size, path, exit and P&L. DVM held 891,225 shares worth $37.423 million at November 2003 ($41.99 each) and 902,625 worth $56.170 million in 2004 ($62.23). Only 21,664 shares remained in 2005, a 97.6% net reduction. The $85 tender was 36.6% above the 2004 mark and 102.4% above the 2003 mark, but neither is a cost-basis return and not every reduced share is proven tendered. A two-for-one split and Anadarko’s $70.50 post-split cash acquisition closed the issuer in August 2006; the flagship position was absent by November. Exact DVM proceeds and total profit remain unknown (2003, 2004, 2005 and 2006 audited reports; Anadarko closing).

Lesson. A capital-return catalyst can shorten the wait in a cyclical value position. Corporate-action arithmetic is useful only when split bases and actual fund transactions remain separate.

8. JPMorgan Chase — buy the write-off, sell at fair value

Context, thesis and dates. DVM added JPMorgan Chase in late 2002 after large write-offs tied to failed telecommunications and energy-trading borrowers. It judged those charges to be one-time, considered management sound and valued the dividend. JPMorgan’s 2003 annual report records falling exposure to telecom, utilities and media and commercial-loan net charge-offs of $816 million versus $1.881 billion in 2002. That supports normalization, but the same report acknowledges prior telecom concentration and Enron exposure; the improving economy and credit cycle also helped (2003 audited flagship report; JPMorgan Chase 2003 annual report).

Size, path, exit and P&L. At November 2002 the flagship held 3,105,075 shares worth $78.155 million, about 2.1% of net assets, at a $25.17 mark. By May 2003 it had cut the position to 474,600 shares marked at $32.86—a 30.6% security-price comparison, not fund return. The shares rebounded sharply and DVM eliminated the position near estimated fair value by November. Cost, sale proceeds, dividends, realized profit and maximum drawdown remain unknown. JPMorgan reappeared in 2004; that is a separate re-entry, not evidence that this round trip stayed open (2002, 2003 semiannual, 2003 and 2004 audited reports).

Lesson. This is the most complete expression of Dreman’s stated process: buy when a conspicuous loss is likely nonrecurring, require a durable franchise and dividend, then sell on valuation rather than narrative momentum. It is also a useful contrast with DVM’s disastrous 2008 bank holdings: a financial stock is not automatically a repeatable contrarian success.

9. Best Buy — rebuild into forced pessimism

Context, thesis and dates. DVM had owned Best Buy years earlier, then began rebuilding the position slowly in fall 2002 as investors worried about market-share losses and the failing Musicland division. It kept adding through weakness because it trusted the core business and management. Musicland itself was not “fixed”: Best Buy sold it for no cash consideration after large impairments and a disposal loss, while the buyer assumed lease liabilities. The successful thesis was that the core stores could gain share despite destruction from the acquisition (2003 audited flagship report; Best Buy Form 10-K).

Size, path, exit and P&L. At November 2002 the flagship held 3,608,470 shares worth $99.882 million ($27.68 each), about 2.7% of assets. It added through weakness to 4,615,570 shares by May 2003; after trimming, only 326,270 shares worth $20.229 million remained in November at a $62 mark. The audited marks rose 124.0%, but additions and sales make that a security-price comparison, not fund return. The same stub remained in 2004 and was gone by November 2005. Cost, realized proceeds, final sale date and maximum drawdown are undisclosed (2002, 2003 semiannual, 2003, 2004 and 2005 audited reports).

Lesson. The operative signal was not merely a low multiple: it was a sound core franchise beside a failed acquisition that could be removed. Scaling in reduced timing dependence, while staged trimming acknowledged that the rerating had harvested part of the contrarian discount.

10. Post-9/11 travel and payments basket — tactical panic buying

Context, thesis and dates. After September 11, 2001, DVM sold Tenet Healthcare and bought American Express plus MGM Mirage, Harrah’s and Park Place during panic selling. Dreman argued that travel would recover and the casino operators owned entrenched, well-secured franchises. This basket is documented by both the flagship report and a contemporaneous profile (2001 audited report; Washington Post, 2001).

Size, path, exit and P&L. At November 2001 American Express was $18.4 million, about 0.4% of fund assets; the three casinos totaled about $34.0 million, or 0.8% (calculated from the audited holdings). Dreman reported dramatic appreciation after September. All four were absent by November 2002, establishing completion by then, but entry prices, sale prices, drawdowns and realized P&L are unavailable. American Express’s reported $25.61 low to $30.72 on October 26 was a 20.0% market-price rebound, not DVM return (2001 audited report; Washington Post, 2001; 2002 audited report).

Lesson. Event panic can create short, small contrarian opportunities, but this approximately 1.2% basket was far less consequential than tobacco. The evidence supports a successful tactical trade, not folklore about every casino stock doubling.

Cross-case assessment

The repeatable pattern was: buy a statistically cheap security after a vivid disappointment; test whether the impairment was temporary; add through price weakness; and reduce or exit as valuation normalized. The best cases had a second catalyst—court decisions for Altria, cost control for Humana, credit normalization for JPMorgan, a divestiture for Best Buy, or merger synergies for Reynolds.

Three cautions prevent hagiography. First, almost every case is a DVM team result reported through a fund, not a Dreman personal trade. Second, the flagship reports are management narratives written after the fact; independent issuer and legal sources can corroborate events, but not always the manager’s causal attribution. Third, commodity prices and court outcomes contributed luck. The evidence supports disciplined contrarian implementation and several profitable sales; it does not support a ranked lifetime P&L table, exact holding-period returns outside Humana’s disclosed sold lots, or the claim that every unpopular stock was a success.

What was excluded

• The 2008 financial-stock collapse is a major failure, not repackaged as a “great trade”; it belongs in the dedicated mistakes analysis.
• Home Depot’s January 2003 purchase and later trim were successful, but the source discloses neither a completed exit nor a measurable realized result strong enough for this top ten.
• Unnamed casino, technology, energy-trading and oil-service sales mentioned in a 2002 variable-portfolio report cannot be reconstructed responsibly.
• Holdings copied from other portfolios inside multi-fund SEC filings were rejected. Proximity in a filing is not evidence of DVM ownership.
• Price-chart backtests, current adjusted-price databases and ending-value differences were not substituted for manager transactions.

Evidence and accounting boundaries

David Dreman's most consequential documented error was not that a contrarian portfolio sometimes lagged. It was that his flagship entered the 2008 crisis with a large common bet on financial institutions whose reported earnings and book values did not measure their economic exposure. [single-source] The flagship's Class A shares lost 45.50% in calendar 2008. [single-source] For the fiscal year ended November 30, Class A lost 47.30% and Class S lost 47.25%. Those are different share classes and periods, not corroborating measurements of one return. [single-source] A related variable-insurance portfolio lost 48.81% in calendar 2008 and must also remain separate (SEC plan filing, 2009; DWS audited flagship report, 2008; DWS VIP annual report, 2009).

Fund returns, firm assets under management (AUM), and Dreman's personal wealth are three different ledgers. AUM can fall because of investment losses, withdrawals, mandate terminations, and product closures; it is not a portfolio return. Firmwide holdings are not necessarily flagship holdings. Security-price changes do not establish realized fund profit or loss without tax lots and cash flows. This chapter therefore quantifies only like-for-like observations and labels reconstructions and single-source figures.

The 2008 bank loss: a broken denominator

The flagship's 45.50% calendar-year Class A decline implies an 83.49% subsequent gain merely to regain the starting value, before distributions, fees, taxes, or cash-flow timing. That recovery hurdle is arithmetic, not a reported fund result: (1/(1-0.455)-1). [single-source] Class S's audited fiscal-year decline was still worse. Its net asset value fell from $50.28 to $23.88 after distributions, and that share class's net assets fell from $288 million to $127 million. The last pair describes only Class S and combines market movement with shareholder flows (SEC plan filing, 2009; DWS audited flagship report, 2008).

[single-source] The audited fundwide ledger is more severe but must not be double-counted. Net operations were negative $3.461 billion, comprising $1.223 billion of realized losses, a $2.350 billion adverse change in unrealized appreciation, and positive investment income. Net assets fell from $8.339 billion to $3.247 billion, a 61.07% contraction, but that larger percentage also incorporates distributions and net redemptions and is not an investor return (DWS audited flagship report, 2008).

[single-source snapshots] Primary portfolio filings show escalation, not merely passive exposure. At November 30, 2007, Fannie Mae, Freddie Mac, and Washington Mutual had a combined $708.0 million market value, 8.49% of fund net assets. By May 31, 2008, six named financial detractors—those three plus KeyCorp, Wachovia, and Bank of America—represented $1.143 billion, or 16.36% of net assets. From May through August, reported share counts rose 188.7% for Fannie, 87.0% for Freddie, 50.5% for Washington Mutual, and 57.6% for KeyCorp. These are derived point-in-time exposures, not tax lots: they document position expansion as prices fell but cannot establish purchase prices or realized loss by company (DWS audited report, 2007; DWS semiannual report, 2008; DWS holdings report, 2008).

This was not an unforeseeable one-day accident. [single-source] Forbes reported that, as of August 30, 2008, approximately 7.4% of the fund was in Fannie Mae, Freddie Mac, Washington Mutual, and Wachovia—four institutions subsequently failed, entered conservatorship, or were forced into rescue transactions. By the June 2009 subadviser termination, the portfolio reportedly still had about 21% in financial stocks. Contemporary reports placed the fund at roughly $2.2–$2.9 billion around the announcement and transition; dates and measurement conventions differ. DWS cited long-term underperformance and replaced Dreman Value Management effective June 1. A primary supplement separately confirms the same date for DVM's replacement on the related VIP portfolio; it does not make the vehicles interchangeable (Forbes, 2009; Money, 2009; New York Times, 2009; Institutional Investor, 2011; SEC VIP supplement, 2009).

The mistake began at the denominator. Low price-to-earnings or price-to-book ratios are informative only if earnings and book equity are economically meaningful. Dreman later said the team could not see how deeply banks were exposed to real estate; structured-credit marks and observable sale prices diverged so far that balance sheets did not reveal true losses. Cheapness therefore became partly circular: the institutions appeared inexpensive because the reported numbers had not yet absorbed the risks that made them inexpensive (Institutional Investor, 2011; GuruFocus interview, 2010).

Portfolio construction compounded the analytical error. Forty or fifty stocks can look diversified while sharing one funding, housing, leverage, and confidence factor. Position count did not neutralize a correlated sector thesis. Dreman had publicly argued in mid-2008 that selected bank shares offered post-crisis opportunity, even while describing mortgage losses and Washington Mutual's capital dilution. He was reasoning from normalized profitability while the range of possible liabilities remained unusually wide (Forbes, 2008; Federal Reserve, 2009).

There was also a sell-discipline contradiction. Dreman's pre-crisis rule was to exit immediately after material bad news that impaired the thesis, yet he later emphasized holding Bank of America, JPMorgan Chase, and Wells Fargo through the collapse. Some survivors subsequently recovered, but survival is not proof that the original position size or downside control was sound. [single-source] In the same flagship, Class A gained 6.46% from November 30, 2008 through May 31, 2009; compounded with the prior fiscal-year loss, it remained 43.90% below its November 2007 starting value and still needed a derived 78.24% gain to recover (Motley Fool interview, 2004; DWS semiannual report, 2009).

A separate, much smaller High Opportunity fund reportedly gained nearly 140% from the March 2009 low, versus just over 100% for the S&P 500. That single-source, endpoint-sensitive comparison concerns another vehicle; shareholders whose flagship subadviser was replaced could not automatically capture it. The comparison shows that some surviving positions rebounded, not that the original flagship recovered (Institutional Investor, 2011).

Fannie and Freddie: the admitted worst investment

Dreman later named Fannie Mae and Freddie Mac his worst investment and attributed the disaster to political pressure to weaken mortgage standards. The located version is a republication of a Globe and Mail interview, so the admission is attributable but the precise fund loss is not independently established. That political explanation is Dreman's retrospective attribution, not an independently established allocation of causation (Hedge Fund Alpha republication, n.d.).

The incomplete part matters because accounting-quality warnings predated the crisis. In 2003, after Freddie disclosed accounting problems, Dreman publicly defended both government-sponsored enterprises on their valuations and histories. [single-source] Subsequent federal findings showed that Fannie had used improper accounting from 1998 through 2004; the SEC said the anticipated restatement would reduce previously reported net income by at least $11 billion, mainly because of hedge-accounting errors. The regulator settled accounting-fraud charges with Fannie in 2006 (Forbes, 2003; SEC litigation release, 2006; SEC settlement announcement, 2006).

Those facts do not mean the 2008 conservatorships were predictable in timing or magnitude. They do mean that a pristine-accounting assumption was already unavailable. The error was therefore broader than government interference: Dreman combined a low-multiple signal with confidence in the GSEs' politically privileged franchises, persisted after governance evidence weakened the denominator, and accepted a payoff structure with a very adverse common-equity left tail. An expectation that government support would protect common shareholders cannot be attributed to Dreman from the located evidence.

The formative glamour-stock loss

Dreman's earliest documented personal loss episode came during the late-1960s glamour-stock reversal. In a 1996 interview he described taking a “leave of absence” from value in 1968 as glamorous growth stocks captivated his professional circle. He recalled colleagues turning modest sums into roughly $300,000 and losing the gains by 1970. A later secondary account says Dreman lost about 75% of his net worth, but Dreman's own 2015 recollection says he was hurt and still retained money. Without account statements, the exact percentage is [unverified]; the direct accounts establish only the behavioral sequence (Los Angeles Times, 1996; Morningstar, 2014; Dreman interview, 2015).

This was a rule-abandonment error rather than a bad implementation of contrarian value. Social proof, recent price gains, and fear of professional obsolescence overrode the method he had used. Dreman's later low-multiple discipline can be read as an institutional response: decide what constitutes cheapness before enthusiasm peaks, require fundamental evidence, diversify, and let a rule rather than the crowd determine the exit. The loss helped generate the process, but its pedagogical value should not romanticize the capital destruction.

Painful omission versus actual mistake

The 1999 technology boom was a severe relative-performance and business-resilience test, not the same investment error; no source located shows that Dreman's job, fund, or firm was near collapse. One retrospective account reports that the fund lost 13% while the S&P 500 gained 21%, a 34-percentage-point gap. In 2000 it reportedly gained 41% as technology shares broke. These figures are single-source and do not specify every share-class or fee convention. They nevertheless illustrate that refusing to buy securities with no defensible valuation anchor can be correct while creating severe client and business risk (Money, 2009).

Calling 1999 an “error of omission” would confuse missing a rising asset with making a poor decision. The subsequent reversal supports the refusal to chase, although one-year vindication does not prove every avoided technology company was overvalued. The real omission lesson is operational: a strategy requiring long periods of visible wrongness needs clients, product terms, and communication capable of surviving the wait. Dreman survived 1999; the flagship mandate did not survive the 2008 drawdown long enough for his preferred recovery argument.

The contrast also prevents a common contrarian fallacy. Disagreement with consensus is not itself evidence of skill. In 1999, the underlying cash-flow skepticism was eventually supported. In 2008, the supposedly conservative accounting inputs deteriorated faster than the portfolio adapted. One episode rewarded patience; the other required falsification.

An earlier bank episode may have made that distinction harder. Dreman reported that the flagship lost about 9% in 1990 while holding banks through a banking crisis, then produced strong subsequent returns. The single published result is retrospective, and Dreman did not say it caused his 2008 decisions. Still, it is a plausible—explicitly inferential—anchoring precedent: adding to financially sound banks on bad news had worked before, encouraging the team to treat a structural balance-sheet break as another cyclical panic (Los Angeles Times, 1996).

A smaller error: missing an industry imbalance

Dreman later described an unquantified oil investment error. Bottom-up company analysis did not give enough weight to excess supply across the industry; the team exited some positions but was still “burned a bit.” No names, dates, vehicle, or amount were disclosed, so it cannot enter the numerical loss ledger. It does provide unusually clean evidence of a process mistake and its repair: add an industry and sector overlay rather than assume issuer analysis alone captures a common factor (Dreman interview, 2015).

Franchise near-death was not portfolio P&L

The crisis damaged more than a fund. Dreman Value Management's AUM fell from roughly $22 billion in late 2007 to $4.7 billion at year-end 2009—more than three quarters—amid losses, redemptions, and the loss of the flagship mandate. Because the observations use nearby dates and may not employ identical definitions, an exact percentage would create false precision (Institutional Investor, 2011; SEC filing, 2010).

Product expansion increased the surface area. A 2007 profile described a $22 billion platform building staff and planning additional long/short products. In 2012, the board of Dreman's proprietary fund complex approved liquidation of five funds because rising regulatory and operating costs made their small asset bases uneconomic. That closure reason is not proof that the 2008 stock calls directly caused every liquidation; it is evidence that, after the drawdown and asset flight, scale no longer supported the range (Institutional Investor, 2007; SEC liquidation filing, 2012).

Franchise contraction continued beyond the proprietary funds. DWS removed DVM from three additional value mandates in 2013; VALIC terminated a small-cap mandate in 2015; and American Beacon replaced DVM with Foundry in June 2016. The filings establish mandate and organizational contraction, not that every decision resulted from the 2008 drawdown (SEC DWS supplement, 2013; SEC VALIC filing, 2015; SEC American Beacon filing, 2017).

The firm later transferred investment leadership to E. Clifton Hoover in 2010. [single-source] Its last located Form ADV, filed in 2018, reported approximately $156.8 million in regulatory AUM, and the IAPD summary accessed 2026-07-20 says the adviser is no longer registered. These observations establish contraction and closure of registration, not bankruptcy, fraud, or a continuously measured fall from the earlier total. The 2018 filing reported no disciplinary events, and Dreman's individual report also lists no disclosure events (DVM succession announcement, 2010; Form ADV, 2018; IAPD firm summary, accessed 2026; IAPD individual report, accessed 2026).

That regulatory boundary is important. DWS's 2009 decision was a commercial subadviser termination, not an enforcement sanction. The 2018 ADV and current IAPD records reviewed for Dreman and DVM disclose no investment-regulatory events, and targeted searches run on 2026-07-20 located no SEC or Department of Justice action against either; that is not an exhaustive representation about every civil docket. An official Florida corporate annual report signed in his name on April 17, 2025 is the strongest recent evidence that he was then living; it is not a 2026 vital-status certification (Florida Division of Corporations, 2025).

A falsified macro forecast

Dreman also made a cleanly falsified post-crisis forecast. In 2010 he predicted 10%–12% inflation once unemployment fell below 6%, a threshold he thought might take about four years. Unemployment reached 5.9% in September 2014, while CPI inflation was then 1.7% year over year. No portfolio P&L can be assigned to the forecast, but it shows that expertise in behavioral finance did not confer macro-timing accuracy (GuruFocus interview, 2010; BLS employment report, 2014; BLS CPI report, 2014).

Behavioral roots

Four analytically inferred failure modes recur across the documented loss record; except where explicitly attributed, they are Canon interpretations rather than Dreman's self-diagnosis.

1. Commitment and identity. Having built a career as a contrarian, Dreman had an incentive to treat worsening prices as confirmation that the crowd was emotional. That is useful only while the thesis remains testable.
2. Denominator blindness. Low multiples were given more weight than the reliability of the earnings and equity to which prices were compared.
3. False diversification. Numerous holdings shared the same housing, leverage, wholesale-funding, and confidence exposures.
4. Path and client blindness. A security can recover eventually while a leveraged institution, a fund shareholder, or a sponsor mandate cannot survive the intervening loss.

Dreman's own postmortem was candid on part of the failure: “our financial holdings cost us a lot.” He also said the team had not understood the depth of bank real-estate exposure. But the explanation sometimes shifted too much responsibility to opaque instruments, bank managers, or politicians. A fiduciary process exists precisely because management accounts, government incentives, and market prices may be unreliable (Money, 2009; Institutional Investor, 2011).

What changed—and what did not

The clearest documented repair was a faster falsification rule. In 2010 Dreman said that when losses made earnings indeterminate, the team should exit much more quickly rather than assume a charge was temporary. By 2012 he described selling a company that reported losses and reconsidering it only after profitability returned. That is a meaningful change: it makes the denominator's failure an exit signal instead of mechanically making the stock look cheaper (GuruFocus interview, 2010; Forbes interview, 2012).

The mature process also emphasized smaller financial positions, wider diversification, industry-relative rather than market-wide comparisons, liquidity, and fundamental screens beyond P/E. Dreman said he would not again weight financial stocks as heavily. These controls reduce—but cannot eliminate—common-factor concentration and unreliable-accounting risk. Dreman did not abandon low-multiple contrarianism; he altered the conditions under which patience was justified (Forbes interview, 2012; DVM ADV brochure, 2014; American Skandia prospectus, 2006).

The evidence is weaker on whether those repairs were tested at the old scale. Leadership moved to Hoover, firm assets never returned to the documented pre-crisis level, and later vehicle results cannot recreate the counterfactual for terminated flagship shareholders. A rebound is evidence that some holdings were oversold; it is not evidence that the drawdown, concentration, and governance controls were acceptable.

Assessment

Dreman's record contains both kinds of contrarian outcome. The late-1960s loss showed the danger of abandoning a rule to join a crowd. The 1999 drought showed the career cost of keeping a valid rule. The 2008 collapse showed that following a value rule can itself become dogmatic when the inputs cease to be trustworthy.

The strongest skill evidence is that he turned an early personal failure into a durable, empirically motivated process and refused the technology mania. The strongest adverse evidence is that the mature organization repeated a deeper form of the same behavioral problem in financials: commitment to an identity displaced timely falsification. His post-crisis exit rule directly addressed that error. It arrived only after a roughly 45% flagship loss, a lost mandate, and a documented franchise contraction; no later public filing located shows a return to pre-crisis scale.

The defensible conclusion is neither that Dreman's contrarian method failed nor that 2008 was an unforeseeable exception. Low valuation remained useful, but only conditional on reliable accounts, survivable balance sheets, independent exposures, and clients able to endure the path. The canon-worthy lesson is that patience is a virtue only after the investor has specified what evidence should end it.

Evidence standard. Research cutoff: 2026-07-21T19:05:10Z. This is a source-critical quotation archive, not a motivational quote list. Each excerpt is 25 words or fewer, identifies its year and source, and is tied to a source visible in this audit. "Primary" means Dreman wrote or spoke the words in an accessible first-party or institutional record. "Primary-adjacent" means a reputable publisher captured an interview, Q&A, shareholder report, or firm statement but the original audio, hard-copy book page, or letterhead is not fully accessible. Dreman Value Management ("DVM") strategy language is labeled as firm language rather than silently converted into personal Dreman speech.

Contrarian value and investor overreaction

Dreman's public voice is unusually consistent across four decades: start with investor error, define "contrarian" with valuation measures, and then insist that cheapness must be tested against survivability. The strongest theme is not simply "buy hated stocks." It is that expectations become most exploitable when the crowd extrapolates too far in either direction.

1. "Contrarian strategies are strategies that have been outperforming the market for over 50 years now." - Wall Street Journal online Q&A, 1998. Direct edited transcript. Dreman immediately named low P/E, low price-to-book, low price-to-cash-flow and high yield as the four practical gauges; the accessible article truncates after the first reader question.

2. "consensus opinion, especially when it comes to investment decisions, is often wrong." - Scudder-Dreman High Return Equity Fund annual report, 2003, portfolio-manager Q&A. SEC-filed primary-adjacent interview. The sentence frames a bottom-up fund review, not a claim that all consensus views are wrong.

3. "I think it's time to get a little less defensive." - Washington Post / Bloomberg profile, 2001. Direct news interview. He was explaining a post-September 11 shift from tobacco-heavy defensiveness toward travel and selected cyclicals, while still avoiding technology.

4. "We look for out-of-favor stocks by specific value benchmarks" - Motley Fool interview excerpt, 2004. Direct interview excerpt. The rest of the answer lists low P/E, low price-to-cash-flow, low price-to-book and high yield; it is a screening doorway, not the full process.

5. "Nobody can answer that." - Motley Fool interview excerpt, Part II, 2004. Direct interview excerpt. Dreman was discussing the uncertainty around Merck's Vioxx liabilities; the comment supports humility about litigation sizing rather than indifference to legal risk.

6. "We spend an enormous amount of time looking at the litigation." - Washington Post / Bloomberg interview, 2005. Direct news interview. This is the best compact answer to the misconception that Dreman bought controversial stocks mechanically.

7. "There should be some excellent buying opportunities near term." - GuruFocus repost of Consuelo Mack WealthTrack transcript, 2007. Secondary transcript of a direct broadcast. Use as near-primary only; the WealthTrack transcript endpoint was not accessible, and WealthTrack now says older transcripts are no longer available.

8. "You always modify." - GuruFocus / Jacob Wolinsky interview, 2010. Direct Q&A. The line introduced Dreman's post-2008 process changes, especially a faster exit from banks and insurers when reported earnings were no longer reliable.

9. "gut instinct is the graveyard of all too many portfolios." - Morningstar interview, 2012. Direct edited interview. Dreman contrasted gut feel with statistical probabilities and broad, equally weighted portfolios.

10. "You never really know when to sell." - Morningstar interview, 2012. Direct edited interview. The complete answer ties humility to a mechanical sell rule: exit as the stock reaches the market multiple and redeploy into cheaper names.

11. "You're almost flying blind, especially in a bubble." - GuruFocus Q&A, 2015. Direct Q&A. Dreman was explaining why banks and insurers became harder to underwrite during the 2008 crisis than ordinary industrial value names.

Process, screens and firm language

Dreman's personal interviews use the pronoun "we" because his public career was inseparable from DVM, mutual funds and subadvisory mandates. The following excerpts are therefore marked carefully. They are useful because they show how the philosophy was translated into fund documents, but they should not be misquoted as off-the-cuff personal aphorisms.

12. "buying undervalued companies with real earnings and cash flow" - Dreman Contrarian Funds annual report, 2011. DVM/fund language in SEC filing. The line is from an annual shareholder report after the post-crisis fund relaunch, and it emphasizes real earnings after the 2008 experience.

13. "overlooked companies with low price-to-earnings ratios" - Dreman High Opportunity Fund summary prospectus, 2012. Advisor strategy language. It is a regulatory description of the Advisor's selection process, not a personal interview sentence.

14. "high yield is a crucial indicator of investment success." - Dreman Domestic Large Cap Over-Reaction Fund registration filing, 2012. Advisor strategy language. The statement links dividend yield with low-P/E securities and later dividend growth, a recurring Dreman theme.

15. "This succession plan has been several years in development" - DVM PR Newswire release, 2010. First-party firm release quoting Dreman. Dreman was handing the CIO role to E. Clifton Hoover while remaining chairman and continuing quantitative research oversight.

Mistakes, stress and humility

The useful Dreman corpus is not all victory-lap contrarianism. His clearest learning statements come after financials collapsed in 2008. The 2011 Institutional Investor profile is especially important because it records both the mistake and the recovery argument in the same piece.

16. "We didn't realize how deeply the banks were invested in real estate." - Institutional Investor profile, 2011. Direct profile quotation. This is the plainest public admission that balance-sheet opacity invalidated part of the low-P/E financial-stock thesis.

17. "They sold at the bottom" - Institutional Investor profile, 2011. Direct profile quotation. Dreman was referring to DWS dismissing DVM as subadviser in 2009; the line is advocacy by the displaced manager, not an independent performance audit.

18. "We knew we were dealing with survivors" - Institutional Investor profile, 2011. Direct profile quotation. This captures the post-crisis recovery thesis in banks, but must be read beside the same profile's AUM decline and 35-45 percent drawdown context.

Research papers and behavioral finance

Dreman's academic and professional-paper language is more valuable than most quote sites because it states the empirical claim behind the investing style. The passages below come from abstracts or uploaded paper text visible in the audit; coauthored papers are attributed to Dreman and coauthors, not to Dreman alone.

19. "their forecasts differ significantly from actual reported earnings." - Dreman and Michael A. Berry, Financial Analysts Journal paper, 1995; visible paper copy. Coauthored research. The study compared 66,100 consensus estimates with reported earnings.

20. "continues for at least 19 quarters following the news." - Dreman and Berry, Financial Analysts Journal abstract, 1995. Coauthored research abstract. The sentence describes long-term reversion favoring low-P/E "worst" stocks after earnings surprises.

21. "regular mispricing of growth and value stocks within industries themselves." - Dreman and Eric A. Lufkin, SSRN abstract, 1997. Coauthored abstract. The paper pushes the contrarian argument inside industries, reducing the risk that a cheap portfolio is merely an industry bet.

22. "We present evidence of overreaction" - Dreman and Lufkin, Journal of Psychology and Financial Markets paper, 2000. Author-uploaded ResearchGate text. The upload states that content was uploaded by David Dreman; ResearchGate is not the publisher of record, so cite the DOI as well when possible.

23. "out-of-favor stocks significantly outperform the market." - Dreman, AIMR Conference Proceedings paper, 2000. Author-uploaded conference text. This is a compact statement of the contrarian premise, not proof that any single Dreman fund would outperform in any particular period.

24. "there are only minor differences in investor sentiment" - Dreman, Stephen Johnson, Donald MacGregor and Paul Slovic, investor-sentiment survey paper, 2001. Coauthored paper. The finding refers to comparing March 2001 sentiment with 1998 survey data after steep market declines.

25. "Imagery and affect can be a powerful basis" - Donald MacGregor, Slovic, Dreman and Berry, imagery/affect paper, 2000. Coauthored behavioral-finance paper. The paper warns that emotionally loaded images of industries or securities can shape perceived worth without much predictive validity.

What the corpus says-and does not say

Dreman's verified language supports four principles. First, he viewed contrarian value as an expectations strategy: the market overvalues popular stocks and undervalues shunned ones because investors overreact. Second, he operationalized that view with low P/E, low price/book, low price/cash-flow and high-yield screens, then filtered for balance-sheet strength, cash flow and survivability. Third, he believed sell discipline had to be rule-based because emotion attaches to long-held disappointments; the common triggers were normalization to the market multiple, a stale thesis after roughly two-and-a-half to three years, or major bad news. Fourth, he understood contrarianism as probabilistic. It increases the odds, but it does not remove uncertainty.

The same corpus also shows the failure mode. In interviews before 2008, Dreman repeatedly emphasized checking whether bad news truly impaired the business. In financial companies during the credit crisis, the reported earnings and balance sheets were not transparent enough to support that judgment. His later line about being "almost flying blind" is therefore central: low multiples were insufficient when the denominator could not be trusted. That distinction should prevent future readers from reducing Dreman to "buy whatever fell."

The record is thin in two places. First, the public material does not provide a full, auditable monthly or annual DVM composite return series. Fund reports, interviews and third-party summaries give fragments. Second, many famous Dreman quotes circulate without page-level provenance. Unless a quote can be traced to a book page, interview, SEC filing, or author-uploaded paper, it belongs in the watchlist rather than in the quote archive.

Annotated index of primary and near-primary materials

Attribution traps and exclusions

Quote aggregators such as QuoteFancy, PictureQuotes, AZQuotes, LibQuotes and Goodreads are excluded as final authorities. They are useful as leads but often strip page numbers, merge book excerpts into standalone aphorisms, or repeat awkward wording that suggests copying rather than verification. The "blood in the streets" line should not be presented as original Dreman; even quote sites frame it as a Rothschild saying.

Several attractive book quotes were also excluded because this run did not obtain readable page images from the 1977, 1979/1980, 1982, 1998 or 2012 books. The Validea and Yahoo/AAII-style strategy summaries can help locate candidate rules, but they do not replace page-level book verification. Forbes 2012 interview pages and YouTube links appeared in search results, but the pages did not open cleanly enough here to quote from snippets or captions.

Reading judgment

Dreman's best language belongs in a behavioral-investing file rather than a simple value-screen checklist. He was fascinated by the way forecast confidence, image, affect and institutional consensus distort prices. The most durable Dreman lesson is therefore not that cheap stocks always work, but that markets repeatedly misprice expectations and that the investor must survive long enough, diversify broadly enough and know enough about the balance sheet for the odds to matter.

The counter-lesson is just as important. In 2008, Dreman's process was damaged by financial statements that did not reveal enough about embedded real estate and derivatives exposure. A faithful reading of his own words requires both sides: the statistical contrarian edge he spent a career documenting, and the humility that cheapness without knowable earnings power can become a trap.

Research completed: 2026-07-25T03:51:49Z.

Scope and Attribution Boundary

David Dreman's writing record is unusually broad for a public-markets investor: five core books, a long but unevenly accessible Forbes column run, several academic and practitioner papers, and SEC-filed fund materials that translate the ideas into portfolio rules. This chapter treats those as three different evidence classes. Books and bylined papers are "works by Dreman"; edited interviews, Forbes clips, and SEC-filed manager Q&As are direct or near-primary interpretive materials; Dreman Value Management prospectuses, ADVs, factsheets, and post-2010 releases are firm/team documents unless the source names Dreman personally (DVM ADV, 2014; Scudder-Dreman annual report, 2003; DVM succession release, 2010).

The main bibliographic traps are: the first strategy book is cataloged by Random House and libraries as 1979, while some Dreman biographies call it 1980; the 1979 Warner paperback Psychology and the Stock Market: Why the Pros Go Wrong and How to Profit appears to be a retitled paperback of the 1977 AMACOM work, not a separate core book; and a 2007/alternate-market New Psychological Breakthrough record shares the later 2012 book's metadata and is best treated as catalog residue, not a sixth book (Google Books, 1979 strategy book; Open Library, 1982 revision; Simon & Schuster, 2012).

Works By Dreman

1. Psychology and the Stock Market: Investment Strategy Beyond Random Walk (1977)

Evidence and access. The safest bibliographic anchor is the Open Library/WorldCat record: AMACOM, New York, 1977, xiii + 306 pages, ISBN 0814454291, with subjects linking investment analysis to psychological aspects of investing (Open Library, 1977). The University of Toledo's market-psychology exhibit separately identifies the 1979 Warner paperback under the retitled subtitle Why the Pros Go Wrong and How to Profit, and describes the book as framing psychology as the missing dimension in stock-market analysis (University of Toledo exhibit, 2024 update).

Central thesis. This is the origin book: Dreman argues that security analysis cannot be understood only as numbers and random-walk theory because professional investors themselves amplify market errors through psychology, overconfidence, group behavior, and recurring decision patterns (University of Toledo exhibit, 2024 update).

Key ideas. The book's key contribution is not yet the fully developed low-P/E rule book, but the behavioral foundation beneath it: professionals can underperform because they share the same crowd errors they claim to arbitrage; investor mistakes recur often enough to be studied; psychological self-knowledge is part of investment edge; expert consensus should be treated as a behavioral object, not a neutral fact; and unpopular securities can become attractive when fear or neglect pushes price below sober value (University of Toledo exhibit, 2024 update).

Best chapters/sections. No authoritative, page-visible table of contents was located for the 1977 AMACOM edition. Use this work as Dreman's behavioral origin statement and avoid chapter-level quotation until a physical copy or verified scan is available (Open Library, 1977).

2. Contrarian Investment Strategy: The Psychology of Stock Market Success (1979 catalog / 1980 Dreman biography usage)

Evidence and access. Google Books and Internet Archive records identify Random House, 1979, 302 pages, ISBN 0394423909; Internet Archive also notes that the 1982 work is the revised edition (Google Books, 1979; Internet Archive, 1979). The date should be written as 1979/1980 when reconciling catalog records with later Dreman biographies (GuruFocus interview biography, 2010).

Central thesis. This is the first systematic contrarian method book: the market repeatedly overpays for admired companies and underpays for unpopular ones because investors and analysts extrapolate too confidently from recent evidence (Google Books, 1979).

Key ideas. Page-visible contents show the opening logic moving through forecasting, the limits of fundamental analysis, and psychological odds. The durable ideas are: forecasting future earnings is much harder than professional models imply; the stock market prices expectations, not just business quality; low expectations can make a mediocre headline a favorable risk/reward; high expectations make glamour stocks fragile; value screens need psychological interpretation; and the contrarian investor's job is to buy unpopular companies with acceptable business fundamentals, not to buy every damaged stock (Google Books, 1979).

Best chapters/sections. From accessible contents, start with "Can You Read the Future?", "Fundamental Analysis - The Slippery Rock," and "Understanding Your Psychological Odds." The hidden sections should not be summarized page-by-page without a borrowed or physical copy (Google Books, 1979).

3. The New Contrarian Investment Strategy (1982)

Evidence and access. Open Library records the Random House 1982 revised edition, xxiii + 343 pages, ISBN 0394523644, and explicitly notes it as a revision of the 1979 first edition (Open Library, 1982).

Central thesis. The safest supported summary is that the 1982 book updates the first strategy book rather than creating a new doctrine. It expands the evidence base and market-environment discussion after the late-1970s/early-1980s inflation, bond, commodity, and valuation regime shifts (Open Library, 1982).

Key ideas. Treat this as the bridge between the early psychological argument and later empirical contrarian strategy. Its implied working ideas are: valuation must be judged against changing macro conditions; low price alone is insufficient without financial strength; severe market regimes create both false bargains and extreme opportunities; the 1970s experience made bond and inflation risk central to equity selection; and contrarian strategy must be updated when the environment changes, while keeping its psychological base intact (Open Library, 1982).

Best chapters/sections. No reliable page-visible table of contents was found. The book should be used for chronology and edition development, not for exact chapter recommendations, until page access is available (Open Library, 1982).

4. Contrarian Investment Strategies: The Next Generation (1998)

Evidence and access. Simon & Schuster published the book in 1998; the best independent professional synopsis is Martin Fridson's two-page Financial Analysts Journal review, which says Dreman combines value-investing research, analytical-bias explanations, and his personal criteria for choosing contrarian stocks (CFA Institute review, 1998).

Central thesis. The 1998 book is Dreman's mature pre-crisis statement: behavioral overreaction is not just a story about individual mistakes, but an empirical system that can be converted into low-P/E, low price/book, low price/cash-flow, and high-yield portfolios (CFA Institute review, 1998; WSJ online Q&A, 1998).

Key ideas. The strongest supported ideas are: value returns need a psychological explanation as well as a statistical one; the analyst community's forecasts are too precise for the uses put on them; favored and unfavored stocks respond asymmetrically to earnings surprises; "best" companies can be poor stocks when expectations are extreme; unpopular companies can be good stocks when expectations are too low; and contrarian screens should be combined with fundamental filters rather than used mechanically (CFA Institute review, 1998; CFA Institute, Dreman/Berry forecast paper, 1995; CFA Institute, Dreman/Berry low-P/E paper, 1995).

Best chapters/sections. The full table of contents was not available from an authoritative open page. Use Fridson's review as the map: read for the research base, bias chapters, and stock-selection criteria; then cross-check any quoted passage against a physical or controlled digital copy (CFA Institute review, 1998).

5. Contrarian Investment Strategies: The Psychological Edge (2012)

Evidence and access. This is the major post-crisis revision: Free Press/Simon & Schuster, January 2012, 496 pages, ISBN 9780743297967; Google Books exposes a useful table of contents and Simon & Schuster frames it as a major revision of Dreman's investment classic (Simon & Schuster, 2012; Google Books, 2012).

Central thesis. The book restates the contrarian edge after 2008: efficient-market theory and conventional volatility-based risk measures understate the damage caused by leverage, liquidity, complexity, affect, and human decision shortcuts, while disciplined contrarian value remains useful when paired with broader risk controls (Simon & Schuster, 2012; Loughran review, 2012).

Key ideas. The strongest ideas are: bubbles are recurring psychological events, not rare curiosities; affect and shortcuts distort probability judgments; analysts and investors still lean too heavily on flawed forecasts; low-multiple contrarian portfolios exploit overreaction; industry-relative cheapness can diversify a low-P/E process; risk should be reframed as permanent loss and crisis fragility, not only volatility; complex products and leverage can make apparently rational markets unstable; and post-crisis investors must build rules that survive fear, euphoria, and liquidity shocks (Google Books, 2012; Loughran review, 2012).

Best chapters/sections. The most useful chapters from the visible table are "Market Overreaction," "Planet of the Bubbles," "The Perils of Affect," "Treacherous Shortcuts in Decision Making," "Flawed Forecasting," "A Powerful Contrarian Approach to Profits," "Profiting from Investors' Overreactions," "Contrarian Strategies Within Industries," "Toward a Better Theory of Risk," and "They're Gambling with Your Money" (Google Books, 2012).

6. Core Academic and Practitioner Papers

Dreman's most important papers are the empirical skeleton beneath the books. The first anchor is Dreman and Michael Berry's Financial Analysts Journal paper "Analyst Forecasting Errors and Their Implications for Security Analysis." It compared 66,100 analyst consensus estimates with reported earnings and concluded that finely calibrated earnings forecasts are unreliable inputs for valuation models (CFA Institute, 1995). The best sections are the methods and implication sections; the key ideas are forecast error, false precision, limited industry-cycle relief, fragile DCF inputs, and the contrarian warning against high-expectation stocks (CFA Institute, 1995).

The second anchor, "Overreaction, Underreaction, and the Low-P/E Effect," links earnings surprises to valuation groups: high-P/E "best" stocks and low-P/E "worst" stocks react asymmetrically, and the return correction continues for at least 19 quarters in the publisher abstract (CFA Institute, 1995). The best sections are the surprise-return tests and the interpretation of mispricing before the earnings event; the key ideas are asymmetric surprise response, mean reversion, overreaction before the news, underreaction during correction, and low-P/E investing as a behavioral rather than purely risk-based anomaly (CFA Institute, 1995).

Dreman and Eric Lufkin's "Do Contrarian Strategies Work Within Industries?" is crucial because it removes the simple sector-bet objection: the question becomes whether cheap stocks inside an industry outperform expensive peers inside the same industry (SSRN abstract, 1997; PM Research record, 1997). Its best section is the within-industry ranking logic; the key ideas are industry-neutral cheapness, relative rather than only absolute valuation, better diversification, and a direct bridge to DVM's later sector/industry grouping process (DVM ADV, 2014).

The 2000-2002 behavioral-finance papers are the psychology layer. "Investor Overreaction: Evidence That Its Basis Is Psychological" argues that return spreads between favored and unfavored stocks are too large relative to changes in earnings, sales, cash flow, margins, and ROE, making psychology a better explanation than fundamentals alone (Taylor & Francis DOI page, 2000; ResearchGate author-uploaded text, 2000). "Investor Overreaction and Contrarian Strategies" is a compact AIMR practitioner statement covering valuation ratios, winners/losers, IPOs, bubbles, panics, and the patience required for correction (ResearchGate author-uploaded text, 2000). "Imagery, Affect, and Financial Judgment" and the March 2001 sentiment survey extend the case beyond stock screens, showing how affective images and stubborn optimism can shape investment judgment after market shocks (ResearchGate, imagery/affect paper; ResearchGate, sentiment survey). "Bubbles and the Role of Analysts' Forecasts" applies the same logic to the internet bubble and analyst incentives; cite the Taylor & Francis page for provenance and use readable mirrors only as access leads (Taylor & Francis, 2002).

7. Bylined Forbes Columns and Accessible Interviews

Dreman's Forbes corpus is a major workstream but not a clean open archive. Search evidence and accessible reposts point to a long run from roughly 1979/1980 through at least 2012, with recurring columns on low-P/E evidence, analyst forecasts, internet-bubble valuation, dividends, index construction, EMH, credit panic, post-crisis banks, inflation, beta, and high-frequency trading (GuruFocus interview biography, 2010; GuruFocus repost of "High-Frequency Follies," 2012). Because Forbes access was inconsistent, the columns are best used as provenance leads unless a page or reputable republication opens.

The best accessible interviews are more reliable for live process. In the 1996 Los Angeles Times Q&A, Dreman identifies low P/E as the High Return fund's primary criterion, adds rising earnings and sell rules, and explains why psychology makes cheap stocks hard to hold (Los Angeles Times, 1996). The 2004 Motley Fool interview is the best sell-discipline source: staged sale at the market multiple, sale after roughly 2.5-3 years if the thesis does not work, and immediate sale after materially thesis-breaking bad news (Motley Fool, 2004). The 2010 GuruFocus interview is the best immediate post-crisis process-change source: Dreman says earnings that become indeterminate require faster exit (GuruFocus, 2010). The 2012 Morningstar interview is the best companion to The Psychological Edge, covering emotions, analyst forecast error, indexing, equal weighting, value traps, market-multiple sells, bonds, and the bank mistake (Morningstar, 2012).

8. SEC-Filed and Regulated Implementation Materials

The SEC-filed Scudder-Dreman High Return Equity Q&As are not books, but they show Dreman's strategy under audit-filed, vehicle-specific conditions. The 2002 annual report names Dreman as lead portfolio manager and frames the bear-market response as adding stocks that had fallen sharply while maintaining high-dividend, low-multiple discipline (Scudder-Dreman annual report, 2002). The 2003 report is the cleanest short statement of the philosophy: consensus is often wrong, the process buys financially solid companies at low P/E, P/B, and P/CF multiples, and sector exposures are residuals of bottom-up stock selection (Scudder-Dreman annual report, 2003). The 2004 report is both process evidence and adverse foreshadowing because it keeps confidence in Fannie Mae and other financials after accounting controversy, before the 2007-2008 crisis exposed the limits of statement-based confidence (Scudder-Dreman annual report, 2004).

Later regulated materials show the institutionalized version of the method. The 2012 High Opportunity and Mid Cap prospectuses define overlooked companies through low P/E, solid financial strength, strong management, dividends, and intrinsic value, while warning that value can remain cheap for long periods and that the advisor's perception may not be realized on schedule (Dreman High Opportunity prospectus, 2012; Dreman Mid Cap prospectus, 2012). The 2014 ADV brochure formalizes the mature workflow: group companies by market cap, sector, and industry; eliminate above-market valuations; select three to four candidates per category; run fundamental analysis; define true risk as permanent capital loss; and check valuation, earnings-power, and balance-sheet risk (DVM ADV, 2014).

Best Works About Dreman, Ranked

1. Martin Fridson's CFA Institute review of The Next Generation (1998). Best short professional map of the 1998 book because it captures the three pillars: value research, analytical bias, and Dreman's own selection criteria (CFA Institute review, 1998).

2. Tim Loughran's review of The Psychological Edge (2012). Best academic review of the post-crisis book. It highlights within-industry cheapness, analyst forecast limits, inflation/bond warnings, leverage/liquidity lessons, and avoidance of complex products, while remaining a review rather than a performance audit (Loughran review, 2012).

3. Lawrence Brown's CFA Institute replies to Dreman/Berry (1996, 1997). Best scholarly pushback. Brown accepts that errors can be large but argues analysts are more useful than Dreman/Berry imply, that trends improve in some samples, and that large/high-coverage firms have smaller errors; these papers keep the anti-forecasting claim from becoming dogma (Brown, 1996; Brown, 1997).

4. Institutional Investor, "David Dreman Sticks to His Contrarian Strategy" (2011). Best adverse profile. It documents financial-stock losses, the AUM fall from the 2007 scale, the DWS firing, Dreman's explanation of hidden bank real-estate exposure, and the post-crisis persistence of the process (Institutional Investor, 2011).

5. Institutional Investor, "Unexpected Behavior" (2007). Best pre-crisis institutional profile. It captures the $22 billion platform, hedge-fund ambitions, long/short extension of the value thesis, and operational buildout before the financial-crisis stress test (Institutional Investor, 2007).

6. New York Times and Money/CNN postmortems (2009). Best contemporaneous accounts of the DWS termination and the style-cycle question, but use them with SEC reports because exact fund, share-class, and vehicle boundaries matter (New York Times/GuruFocus repost, 2009; Money, 2009).

7. CBS MoneyWatch flagship postmortem (2009). Useful independent reconstruction of scale decay and the gap between long-term reputation and investor experience, but treat numerical series as single-source unless tied to audited fund reports (CBS MoneyWatch, 2009).

8. Washington Post/Bloomberg profile on Altria and other controversy trades (2005). Best readable profile of how Dreman applied legal-risk discounting to tobacco, pharma, energy, and GSEs before the later financial-stock failure (Washington Post/Bloomberg, 2005).

9. Lakonishok, Shleifer, and Vishny's "Contrarian Investment, Extrapolation, and Risk" (1994). Not about Dreman, but it is the best independent behavioral-value comparator: value returns are framed as investor-extrapolation errors rather than compensation for higher fundamental risk (NBER/IDEAS record, 1993/1994).

10. Lu Zhang's "The Value Premium" (2005). Not about Dreman, but the best clean counterweight to a purely psychological interpretation because it explains the value premium through rational expectations, costly reversibility, and bad-times risk (IDEAS/RePEc, 2005).

11. CXO Advisory's "David Dreman: About Value." Useful as a small-sample forecast-grading caveat for Dreman's public calls; it should not be treated as a fund-performance audit (CXO Advisory).

12. AAII/Validea style summaries. Useful for seeing how Dreman's rules were later translated into retail screens, but they are derivative and should never outrank Dreman's books, papers, fund filings, or interviews (AAII, 2026; Validea).

Exclusions and Open Citation Problems

Quote aggregators, unattributed book-summary sites, unauthorized PDF/Scribd copies, and AI-like summaries were excluded from final quotation authority. The main unresolved gaps are chapter-level access to the 1977, 1982, and full 1998 books; complete verification of the Forbes column archive; and full-text access to a few short Journal of Behavioral Finance editorials such as "Bubble Jr." and "The Influence of Affect on Investor Decision-Making" (Taylor & Francis issue page, 2003; Taylor & Francis, affect commentary, 2004).

Research completed: 2026-07-25T07:17:05Z. Task T0736 is a stale-claim retry. This file separates David Dreman's own behavioral-finance writings from Dreman Value Management (DVM) product filings and from third-party reconstructions of his strategy.

Evidence boundary

The strongest current regulatory boundary is that Dreman Value Management LLC's IAPD firm page says the adviser is not currently registered and not filing reports with the SEC or any state; the latest full Form ADV located is the March 29, 2018 annual amendment, which reported Dreman as chairman, chief investment officer, chief compliance officer and 75%+ control person, with $156.8 million of discretionary regulatory assets under management across 22 accounts (SEC/IAPD, 2026; DVM Form ADV, 2018). The mental models below therefore attribute post-2010 product language to DVM or its named team unless the source quotes Dreman personally. This matters because many later documents describe a team process under Clifton Hoover and other portfolio managers, not a single personal account.

The evidence base is unusually good for the ideas - Dreman wrote books, coauthored empirical papers and gave long interviews - but weaker for personal position-level ledgers. For mental-model purposes, that means we can reconstruct a robust decision process, while being careful not to imply that every DWS, Scudder, Claymore or Dreman Contrarian product holding was Dreman's personal trade.

Named heuristics & frameworks

1. Judgmental heuristics as recurring market errors - Dreman-used behavioral framework

Dreman's broadest mental model is that investors are not reliable intuitive statisticians. In his adapted chapter "Heuristics in Investor Decision Making," he argues that people simplify large information sets by using rules of thumb; these shortcuts usually help in daily life but produce repeated investment mistakes under uncertainty (Dreman, 1998). The investment translation is simple: the market is not merely a machine for discounting facts; it is also a machine for amplifying biased probability judgments. A Dreman-style investor tries to profit where the crowd's simplified story has become more vivid than the base-rate evidence.

2. Representativeness - Dreman-used behavioral term

Representativeness is the habit of treating a new event as if it belongs to a familiar category because the surface resemblance is strong. Dreman's examples include investors comparing the 1987 crash to 1929, or an oil scare to the 1970s oil shocks, while ignoring material differences in valuation, economic conditions and supply context (Dreman, 1998). In security selection, this becomes the mistake of treating an out-of-favor company as a permanent member of a hated category: all banks after a crisis, all tobacco companies under litigation, all airlines after a disruption, all retailers after a bad quarter. Dreman's contrarian move is not to deny the category, but to ask whether the resemblance is superficial and the fundamental base rate more forgiving.

3. Law of small numbers - Dreman-used behavioral term

Dreman borrowed the Tversky/Kahneman idea that people overread tiny samples. He applies it to hot funds, analysts, economic releases and short-term stock reactions: one good call, a few strong quarters or a brief style cycle can masquerade as durable skill or durable impairment (Dreman, 1998). This model explains two sides of his process. First, he distrusted glamour stocks whose recent excellence was being extrapolated. Second, he was willing to buy low-expectation stocks where a bad sample had been overgeneralized.

4. Case rate versus base rate - Dreman-used behavioral term

Dreman repeatedly contrasts vivid case facts with base-rate evidence. In the chapter, the investor error is to become absorbed in the special story and neglect prior probabilities; he explicitly says that the more complex and uncertain the situation, the more investors should consult the historical success or failure rate of similar situations (Dreman, 1998). In his portfolio work, that maps to buying statistically unpopular securities only when the historical class - low P/E, low price/book, low price/cash-flow or high-yield stocks - has favorable long-term odds.

5. Regression to the mean - Dreman-used behavioral term

Regression to the mean is the stabilizer in the Dreman worldview. Investors tend to believe extreme recent returns or extreme corporate disappointments are the new normal. Dreman's contrarian strategy instead assumes that both investor expectations and business results often mean-revert, with the largest payoff when expectations are already low (Dreman, 1998). His coauthored CFA paper on earnings surprises supports this: low-P/E "worst" stocks and high-P/E "best" stocks reacted asymmetrically to earnings surprises, and the low-P/E group continued to show above-market returns for at least 19 quarters after the news (Dreman and Berry, 1995).

6. Availability and affect - Dreman-used behavioral terms

Availability is the over-weighting of recent, memorable or emotionally charged facts. Dreman describes how salient disasters and recent trends pull investors away from long-term valuation guidelines (Dreman, 1998). This helps explain why his best examples often begin with bad press, litigation, panic or a sudden earnings miss: the news is real, but the question is whether the emotional salience has moved price farther than the long-run economics have moved value.

7. Input-output matching - Dreman-used behavioral term

Dreman's input-output model says investors expect good inputs to produce quick good outputs and bad inputs to produce immediate bad outputs. If a cheap stock does not rise quickly, the crowd asks why the thesis is not working; if a glamour stock rises, the price action confirms the story. Dreman's answer is patience: value may not be recognized in price for quite some time (Dreman, 1998). This model underlies the long holding periods, the tolerance for tracking error and the explicit sell rule only after a thesis has had enough time to work.

8. Forecast-error humility - Dreman-authored empirical framework

Dreman and Michael Berry compared 66,100 consensus analyst earnings estimates with reported earnings and found large, persistent errors that called into question the use of finely calibrated earnings forecasts in valuation models (Dreman and Berry, 1995). The investing rule is not "ignore earnings"; it is "do not pay a high multiple for a precise forecast." Low expectations provide a margin against forecast error. High expectations require forecast accuracy that analysts often do not deliver.

9. Expectations arbitrage - reconstructed operational framework

Dreman did not need to call it "expectations arbitrage" for the logic to be visible. The trade is to buy when the embedded expectation is already poor, then let normal business resilience, mean reversion or a merely less-bad outcome reprice the stock. DVM's 2014 Morgan Stanley profile describes the Large Cap Value strategy as bottom-up, contrarian and low-P/E based, screening for companies with strong fundamentals, earnings and dividend history, and then using additional screens for price/book, price/cash-flow and dividend yield (Morgan Stanley/DVM, 2014). This is a practical version of Dreman's psychology: pay for low expectations, then require evidence that the business is not permanently impaired.

10. Survivable denominator - reconstructed post-2008 repair rule

The great repair to the model after 2008 is that the denominator in a low P/E ratio must be real. Dreman's financial-stock losses showed that a stock can look statistically cheap because the "E" is unreliable, not because the market is overreacting. Institutional Investor reported that Dreman funds heavy in banks and financials fell 35% to 45%, and Dreman admitted, "We didn't realize how deeply the banks were invested in real estate" (Institutional Investor, 2011). The resulting model is not simply "buy low P/E"; it is "buy low P/E only after testing whether earnings, book value, leverage and liquidity are observable enough to trust."

Their decision checklist, reconstructed in operational terms

1. Define the investable universe and vehicle constraints. Dreman's product filings varied by mandate, so the first step is to know whether the strategy is large cap, small cap, income, domestic, international, long-only or long/short. A 2012 Dreman Contrarian Funds filing, for example, described a domestic large-cap overreaction fund with its own policies, risks and portfolio-management structure (SEC, 2012).

2. Start with valuation, not story. Screen for stocks with P/E multiples below the market, then cross-check price/book, price/cash-flow and dividend yield. The Morgan Stanley profile lists those additional quantitative screens, while Validea's derivative model separately interprets Dreman as favoring low P/E, price/book, price/dividend and price/cash-flow ratios; Validea should be treated as a third-party model, not Dreman-endorsed performance evidence (Morgan Stanley/DVM, 2014; Validea, 2026).

3. Prefer low expectations within comparable groups. DVM filings and profiles describe a bottom-up process, but the point is not to compare a bank mechanically with a drug company or an airline. The better reconstruction is to rank within sectors, industries and market-cap categories so that a low multiple reflects excess pessimism rather than a structurally different business model (DVM ADV brochure, 2014).

4. Ask what the market thinks is wrong. Identify the visible negative: earnings miss, litigation, accounting scare, product issue, cyclical trough, regulation, panic, sector stigma or forced selling. Dreman's 2003 Scudder-Dreman report describes Best Buy and Home Depot as purchases or additions after temporary setbacks, and tobacco as a litigation-fear opportunity where dividends and discounted valuation still supported the position (Scudder-Dreman annual report, 2003).

5. Separate temporary disappointment from permanent impairment. This is the heart of the model. A temporary disappointment has survivable finances, continuing earnings power and a plausible route to normalized expectations. A permanent impairment has a broken balance sheet, obsolete product, fraudulent accounting, regulatory insolvency, unfinanceable leverage or economics that cannot support the old earnings.

6. Do not build the thesis on precise forecasts. Use forecasts as rough inputs only. The 66,100-estimate Dreman/Berry study is a direct warning that calibrated analyst earnings numbers are too fragile to justify paying for perfection (Dreman and Berry, 1995).

7. Test financial strength before calling it cheap. The 2014 DVM profile says fundamental analysis focused on balance-sheet strength, cash flow, debt-to-capital ratios, management quality, strong financials and sustainable earnings growth (Morgan Stanley/DVM, 2014). The 2012 Dreman fund filing similarly describes financial strength, management quality, dividend profile and other fundamental screens as part of the process (SEC, 2012).

8. For financial companies, add an opacity discount. Post-2008, the checklist needs a special stop sign for banks, insurers, GSEs, mortgage lenders and leveraged vehicles. If assets, funding, off-balance-sheet exposure or capital needs cannot be understood, low P/E and low price/book are not sufficient. DVM's own March 2008 13F shows large firmwide common-stock exposure to financial names such as Citigroup, Bank of America, Fannie Mae and Freddie Mac; 13F data are long U.S.-listed securities only and not a personal Dreman account (DVM 13F, 2008).

9. Use dividends as corroboration, not a substitute for solvency. Dividend yield matters in Dreman's process because a falling price raises the yield and can create paid-to-wait asymmetry. But dividends are not a magic shield. The Dreman/Claymore 2006 report shows how income-oriented products could carry heavy tobacco, thrift/mortgage, bank and preferred-stock exposure, which later illustrates how yield can cluster into shared balance-sheet risk (Dreman/Claymore semiannual report, 2006).

10. Diversify as a statistical edge, not as decoration. Dreman's model is probabilistic. The individual name can be wrong, so the portfolio should express the base-rate advantage across enough names. The 2014 Morgan Stanley profile lists 40 to 60 target stock holdings and a 0% to 5% cash range for the large-cap strategy; it also warns that the approach can have low benchmark adherence and sector over- or underweights (Morgan Stanley/DVM, 2014).

11. Watch factor concentration beneath name count. A portfolio with 50 holdings can still be one bet if many holdings depend on housing credit, litigation outcomes, commodity prices or a regulatory cycle. The 2006 Dreman/Claymore report's industry breakdown included 22.0% tobacco, 16.1% thrift and mortgage finance, 15.5% commercial banks and 7.6% insurance, showing how a value/income mandate can become concentrated in a few disliked but correlated risk pools (Dreman/Claymore semiannual report, 2006).

12. Sell for valuation normalization. The cleanest sell rule is to reduce or exit when valuation reaches or exceeds the market multiple. DVM's 2014 profile says stocks are generally sold when the P/E rises above the S&P 500, when fundamentals unexpectedly change or when price keeps languishing despite earnings improvement (Morgan Stanley/DVM, 2014).

13. Sell when the thesis is stale. Dreman interviews and prior source work support a two-and-a-half-to-three-year patience window: if the company is good and the thesis is right, it should usually begin to work within that period. Treat this as an approximate discipline, not a universal product rule, because public products show different turnover rates and constraints.

14. Sell immediately when the premise breaks. If the adverse news is not merely sentiment but a fundamental change - sustained losses, capital impairment, dividend unsustainability, fraud, liquidity crisis, or a business model that no longer earns the old returns - the contrarian label is no protection. The 2008 mistake shows the cost of waiting when the denominator becomes indeterminate (Money, 2009; Institutional Investor, 2011).

15. Maintain attribution hygiene. When studying Dreman, ask: is this David Dreman's own book or interview, a DVM team process, a DWS/Scudder subadvised fund, a Dreman Contrarian product, a 13F snapshot, a third-party model, or an academic paper about value? The answer determines how much weight the evidence should receive.

Failure modes of the model

Broken earnings and book value

The central failure mode is buying apparent cheapness when the accounting denominator is wrong. Banks, GSEs and mortgage-exposed financials looked cheap on trailing earnings and book value before the full housing-credit damage surfaced. DVM's March 2008 13F confirms firmwide exposure to multiple crisis financials, while Money's 2009 account named Fannie Mae, Freddie Mac, Wachovia and Washington Mutual as major problem holdings for the High Return fund and reported a 46% 2008 loss (DVM 13F, 2008; Money, 2009). The model failed because it treated low expectations as overreaction before verifying that capital and earnings were still measurable.

False diversification

Dreman-style portfolios can own many securities and still share one underlying exposure. Financials in 2007-2008 were not independent cheap stocks; many were different expressions of credit, housing, leverage and confidence. This is not a refutation of contrarian value, but it is a warning that name count is weaker than driver diversification.

Every fall can look like an overreaction

The same temperament that makes a contrarian brave can make him slow. Dreman's mental model asks investors to step away from vivid bad news, but some bad news is not merely vivid; it is diagnostic. In 2008, refusing to sell banks because they looked like survivors preserved optionality, but it also exposed the process to a deeper capital-structure impairment than the screens captured (Institutional Investor, 2011).

Sponsor and client path risk

Even if a value style eventually rebounds, the vehicle may not survive the path. DWS removed DVM as subadviser of the DWS Dreman High Return Equity Fund effective June 2009, after severe underperformance; Institutional Investor separately reports Dreman's firm AUM dropped from $22 billion in late 2007 to $4.7 billion by year-end 2009 (Money, 2009; Institutional Investor, 2011). A model that requires patience must be paired with clients, funding and governance that can tolerate multi-year tracking error.

Cheapness can be compensation for real risk

Dreman's interpretation emphasizes behavioral mispricing, but the academic value-premium debate is not one-sided. Lakonishok, Shleifer and Vishny argued that value strategies exploit investor mistakes rather than greater fundamental risk, aligning with Dreman's view (Lakonishok, Shleifer and Vishny, 1993/1994). Lu Zhang's neoclassical model argues the value premium can arise because value firms are riskier in bad times due to costly reversibility and a countercyclical price of risk (Zhang, 2005). A Dreman investor should therefore avoid claiming that all excess return is mispricing; some may be payment for bearing real distress risk.

Product-language drift and founder halo

Late DVM documents often combine founder legacy, team process and product-specific constraints. Dreman's name can create a halo around rules that were actually implemented by a team, in different vehicles, under different mandates. The 2018 ADV proves Dreman's control and titles at that date, but it does not make every product outcome a personal discretionary Dreman decision (DVM Form ADV, 2018).

Transferability: what an individual investor can and cannot replicate

What can be replicated

An individual investor can replicate the first principles better than the institutional apparatus. The transferable core is: start with low expectations, require multiple valuation signals, distrust precise forecasts, compare against base rates, diversify broadly, and prewrite sell rules. These do not require proprietary data. They require temperament and record keeping.

The most practical retail version is a two-stage screen. Stage one: find liquid, profitable companies with below-market P/E, low price/book or price/cash-flow, and an above-market dividend yield where appropriate. Stage two: reject value traps with weak balance sheets, unstable financing, secularly declining economics, opaque assets or reported losses that make the denominator unreliable. The individual should treat Validea/AAII-style screens as idea generators only, not as proof of what Dreman actually owned or what will work next (Validea, 2026).

A patient investor can also replicate Dreman's psychological antidotes. Before buying, write down the base-rate class: "cheap cyclical after earnings miss," "litigation discount," "financial with opaque assets," "post-panic airline," and so on. Then ask what usually happens to that class, not just whether today's story is emotionally compelling. Before selling, ask whether the original impairment thesis is broken or whether the price simply has not matched value quickly enough.

What cannot be replicated cleanly

Most individuals cannot replicate DVM's research infrastructure, institutional access, trade execution, portfolio accounting, committee process, compliance apparatus or ability to build 40-60 name separately managed accounts across client mandates. They also cannot replicate the business risk of running a subadvisory platform: fee pressure, sponsor decisions, consultant reviews and style-cycle redemptions.

Individuals also should not assume they can evaluate opaque financial institutions as well as diversified common-stock businesses. Dreman's 2008 error is precisely the warning. When earnings depend on loan marks, structured credit, regulatory capital, short-term funding, embedded leverage or management's own uncertain asset marks, the individual investor's information disadvantage widens sharply.

Finally, an individual cannot replicate the historical low-P/E premium by slogan. The Dreman model is not "buy the cheapest thing." It is a checklist for buying statistically unpopular but still economically alive businesses. The difference is everything.

Source notes and open questions

Sources used for this task include Dreman's own behavioral chapter, two Dreman/Berry CFA papers, DVM's 2014 Morgan Stanley profile, the 2018 ADV, the IAPD firm summary, the 2012 Dreman Contrarian Funds registration filing, Scudder-Dreman and Dreman/Claymore SEC shareholder reports, DVM's 2008 13F, Institutional Investor's 2011 postmortem, Money's 2009 DWS-removal article, Validea's explicitly non-endorsed strategy reconstruction, and two academic value-premium comparators. This exceeds the 10-source minimum and deliberately weights primary or near-primary sources first.

Open questions for the future H-synthesis task: the exact post-2008 version of Dreman's loss-reporting sell rule should still be page-verified against the original Forbes or Morningstar interview; DVM's ADV Part 2 brochure for 2018 was not recovered in this run; and public evidence still does not provide a clean personal Dreman trading ledger distinct from DVM, DWS, Scudder and Dreman/Claymore vehicles.

Research completed: 2026-07-25T08:15:53Z. Evidence boundary: this synthesis is built from the completed A-G Dreman files, refreshed current-status searches, and the Task H source map appended to sources.md. The strongest current public boundary is that Dreman Value Management is not currently registered or reporting with IAPD; the latest full ADV located is the 2018 filing, and no Dreman-specific SEC/DOJ enforcement action or death notice was found in targeted searches through 2026-07-25.

Executive Brief

David Dreman's canon contribution is not the slogan "be contrarian." It is a repeatable way to make contrarianism less theatrical: start where expectations are already low, insist on observable valuation support, assume analysts and crowds extrapolate too confidently, and diversify enough to survive the years when cheap stocks get cheaper. Born in Winnipeg in 1936 and trained in finance before founding the predecessor of Dreman Value Management in the late 1970s, he became one of the clearest practitioner bridges between Graham-and-Dodd value investing and behavioral finance, with books, papers, Forbes columns, mutual-fund mandates, and SEC-filed products all expressing the same central claim: investors overreact to disappointment and underprice companies with low multiples and survivable fundamentals (University of Manitoba; SEC 2007 adviser filing; CFA forecast-error paper).

His edge was strongest when the accounting denominator was real and the market's disgust was emotional, temporary, or litigation-driven. The Dreman record contains good examples of that pattern in tobacco, health care, energy, JPMorgan, Best Buy, and Ryanair, but most trade-level evidence belongs to funds, DVM accounts, or team decisions rather than a transparent personal ledger (2003 audited fund report; Institutional Investor Ryanair profile). His best writings also attack false precision: Dreman and Berry's 66,100-estimate study and the low-P/E earnings-surprise work make analyst forecast error a feature, not a nuisance, of the market environment (CFA Dreman/Berry; CFA low-P/E surprise paper).

His usefulness for the Canon is therefore double-edged. He gives investors a simple antidote to glamour: ask what disappointment is already priced, then demand evidence that the business can outlast that disappointment. He also warns that behavioral confidence can harden into a mirror image of the crowd's error. When cheapness is caused by real insolvency, fraud, leverage, or a collapsing industry structure, the investor is not being paid for bravery. He is volunteering to be the residual risk bearer later in the cycle.

Read as a canon case, Dreman is less a hero of stubbornness than a warning about disciplined stubbornness. The same temperament that lets an investor buy when institutions are embarrassed must also permit reversal when evidence breaks. His best transferable habit is moving from crowd psychology to testable questions: what is implied, what must survive, what would change the decision, and who controls the time horizon? That makes him teachable even where the full DVM track record remains incomplete and still partially vehicle-bound publicly today.

The same evidence prevents hagiography. In 2008, Dreman/DVM owned financials that looked statistically cheap but carried hidden balance-sheet impairment; the flagship Class A lost 45.50% in calendar 2008, DWS removed DVM, and DVM AUM reportedly fell from $22 billion in late 2007 to $4.7 billion by year-end 2009 (SEC plan filing; Institutional Investor; Money). Dreman's mature lesson is therefore conditional: buy unpopular, low-expectation securities only when the fundamentals can survive independent stress tests. The transferable part is the discipline of base rates, valuation, patience, and humility; the non-transferable part is pretending a screen can see through every sector-specific balance sheet.

Ten Transferable Lessons, Ranked

1. Separate contrarianism from mere disagreement. Dreman's method begins with observable low expectations: low P/E first, then supporting evidence from price/book, price/cash flow, dividend yield, financial strength, and management quality. The Morgan Stanley strategy profile describes the mature DVM large-cap process as bottom-up, low-P/E, and fundamentally tested, with 40-60 target holdings, modest cash, and sales when valuation, fundamentals, or stagnation invalidate the case (Morgan Stanley profile). The lesson is not to oppose consensus for sport; it is to ask whether the consensus has already been capitalized into a price that gives the investor several independent ways to be approximately right.

2. Treat forecast precision as a liability. Dreman's research corpus repeatedly turns analyst forecasting error into an investment premise. Dreman and Berry studied 66,100 consensus estimates and argued that the scale of forecast errors weakened the practical value of finely calibrated earnings estimates; the low-P/E earnings-surprise paper extended the point by showing favorable asymmetry when unpopular stocks receive good news and popular stocks disappoint (CFA forecast-error paper; CFA low-P/E surprise paper). The transferrable rule is to build valuation around ranges, base rates, and adverse cases rather than a single elegant spreadsheet.

3. Buy low expectations, not low quality. The mature DVM documents do not read like a junk-value screen. The 2014 ADV describes behavioral finance as the firm's premise, but also says the process groups candidates by market cap, sector, and industry, then uses valuation and fundamental work to separate deserved cheapness from market neglect (DVM 2014 ADV). The 2012 overreaction-fund registration similarly references financial strength, management, dividend policy, and quantitative overreaction screens (SEC overreaction fund filing). The lesson for a smaller investor is blunt: cheap is only an entry ticket; survivability is the test.

4. Respect accounting denominators before trusting valuation ratios. Dreman's most important failure was not that he bought unpopular financial stocks; that fit the system. The problem was that the earnings, book values, and real-estate exposures behind the ratios were less reliable than the screen implied. The March 2008 DVM 13F shows large firmwide U.S.-listed financial positions, including banks, insurers, and government-sponsored enterprises, while later accounts report that the funds were heavily exposed to financials during the crisis (DVM Q1 2008 13F; Institutional Investor). The practical lesson: if the denominator can disappear, a low multiple is not a margin of safety.

5. Diversification is a survival device, not proof of independence. Dreman often recommended broad portfolios for individuals, and DVM product materials used 40-60 holdings for some large-cap strategies. But the 2008 episode shows that many different financial names can still be one macro balance-sheet bet. Diversification has to be measured by source of risk, not ticker count. The 2003 audited flagship report shows real implementation details, including named holdings, sector exposure, turnover, and manager commentary, while later product profiles show low benchmark adherence and sector over/underweights as an expected outcome (2003 audited fund report; Morgan Stanley profile).

6. Use behavioral finance as a checklist, not a story after the fact. Dreman's behavioral frame is strongest when it makes the investor ask specific questions: are we extrapolating a recent disappointment too far, confusing a small sample with destiny, ignoring base rates, or letting availability and affect dominate evidence? His heuristics chapter and related writings place representativeness, regression to the mean, and availability at the center of investor error (Dreman heuristics chapter). Used well, this is pre-mortem discipline. Used poorly, it becomes a flattering story that every falling stock is merely misunderstood.

7. Sell rules matter because value investing can rationalize delay forever. Dreman's sell discipline appears in interviews and product documents as three recurring exits: sell when valuation normalizes, sell when a thesis stagnates despite adequate time, and sell immediately when material bad news breaks the premise. The Morgan Stanley profile gives the institutional version, and the 2010 post-crisis interview preserved in the Dreman source map adds a harder repair rule after banks: if earnings become indeterminate, do not keep averaging down as though the old denominator still holds (Morgan Stanley profile; GuruFocus 2010 interview).

8. Institutional vehicles can break even when the thesis later rebounds. Dreman argued that some banks later recovered, but the business consequence was immediate: DWS removed DVM from the flagship mandate, and firm assets shrank dramatically. DVM's 2010 succession announcement then formalized Hoover's CIO role while keeping Dreman as chairman and investment-committee participant (PRNewswire succession release). The transferable lesson is that path risk is real. A portfolio that recovers too late for clients, boards, or leverage providers may still be a practical failure.

9. Factor evidence needs an opposing model. Dreman's interpretation belongs with the behavioral-value tradition: Lakonishok, Shleifer, and Vishny also argued that value strategies exploit extrapolation errors rather than simply bearing more fundamental risk (LSV). But Lu Zhang's production-based account treats value firms as riskier in bad states, and broader factor work shows that value can be persistent, crowded, painful, and regime dependent (Zhang; AQR value and momentum). The lesson is to use Dreman as a hypothesis generator, not a complete theory of expected return.

10. Do not clone the visible screen and ignore the invisible institution. Derivative models such as Validea and AAII translate Dreman into public-data screens, which can be useful for idea generation but are not evidence of DVM's actual results, trading, research meetings, tax lots, or client constraints (Validea Dreman model; AAII Dreman screen). Individuals can copy the habit of demanding low expectations plus balance-sheet survival. They cannot copy DVM's historical mandate mix, institutional access, trading costs, or sponsor relationships from a web screen.

Style Taxonomy Tags

• Primary style: Contrarian value / low-expectations investing.
• Signal family: Low P/E first; supporting price/book, price/cash flow, dividend yield, industry-relative valuation, and fundamental strength checks.
• Research engine: Behavioral-finance hypothesis plus bottom-up security analysis; later DVM process documents add sector/industry grouping, quantitative screens, and investment-committee/team governance.
• Portfolio construction: Diversified active long-only public equities, with 40-60 holdings in the Morgan Stanley large-cap profile and broader equal-weight guidance in some individual-investor interviews; low benchmark adherence accepted.
• Risk definition: Permanent capital loss, broken fundamentals, valuation-denominator failure, and client/sponsor path risk rather than volatility alone.
• Best evidence type: Dreman books and papers for philosophy; SEC filings and audited fund reports for implementation; Institutional Investor, Money, and contemporaneous press for adverse case study; ADV/IAPD for current regulatory boundary.
• Attribution caveat: Dreman-personal evidence is strongest for books, papers, columns, and interviews. DVM and fund documents after the Hoover/Woodard era should be described as DVM/team/product evidence unless Dreman is personally named.

Regime Dependence

Dreman's approach works best when three conditions align. First, the market is over-extrapolating a disappointment that is painful but not fatal. That is the tobacco, litigation, health-care, oil-spill, post-9/11, and cyclical-recovery version of the playbook: investors demand a high embarrassment premium, the company survives, and modest normalization creates attractive returns (Washington Post Altria profile; DOJ Philip Morris petition; Altria UST closing). Second, the valuation denominator is stable enough that a low multiple really means low expectations, not accounting fog. Third, client capital is patient enough to wait through underperformance without forcing a manager into sponsor risk.

The strategy struggles in glamour-led bull markets, but that kind of struggle can be tolerable if the avoided stocks are truly overvalued. The late-1990s episode belongs in that category: Dreman looked wrong in 1999 and recovered in 2000, a pattern that supports patience but should not be overstated as proof that all underperformance is virtuous (Money). The harsher regime is systemic balance-sheet impairment. In 2008, cheap financial stocks were not just disliked; many were opaque, levered, dependent on policy rescue, and exposed to collapsing real-estate credit. That is when Dreman's behavioral model needed a harder solvency model than the public evidence shows.

The present-day transfer question is also regime-sensitive. Value screens remain widely available, factor premia are more institutionalized, and many cheap companies are cheap for structural reasons. Dreman's behavioral discipline still helps, but its edge is thinner when everyone can run the same screen and when intangibles, platform economics, and financial engineering make historical book and earnings data less comparable. The durable part is not a single ratio. It is the practice of asking what expectation is embedded in price, why the crowd may be wrong, what would falsify the thesis, and whether the investor can survive the path.

One more regime boundary is the client-liability regime. Dreman's discipline asks for embarrassment tolerance, but the vehicles through which most assets were managed were public funds, subadvised mandates, and separate accounts with boards, consultants, sponsors, taxable clients, and style-box comparisons. That structure can convert a temporary mark-to-market loss into a business event. The 2008 episode therefore belongs in two ledgers at once: the investment ledger, where some securities later recovered and others were permanently impaired, and the franchise ledger, where a manager can lose the mandate before the thesis has time to prove or disprove itself. This is why Dreman is more transferable as a decision process than as a portfolio template. A private investor can choose a time horizon. An institutional manager must also underwrite the patience of intermediaries.

Closest and Most-Opposite Investors Already in Repo

Closest: Benjamin Graham. Dreman is downstream from Graham in using price as protection and treating stocks as claims on business value, but he adds a behavioral explanation for why neglected securities become available. Graham is more balance-sheet and margin-of-safety first; Dreman is more expectations and overreaction first.

Closest: John Neff. Neff and Dreman share low-P/E discipline, dividends, public mutual-fund implementation, and willingness to look dull while glamour leads. Neff's version is more total-return and earnings-growth balanced; Dreman's is more explicitly behavioral and academic.

Closest: Geraldine Weiss. Weiss and Dreman both turned public-data contrarian value into rules a disciplined individual could understand. Weiss centered company-specific dividend-yield ranges; Dreman centered low expectations across valuation ratios and psychology.

Closest but more defensive: Jean-Marie Eveillard. Eveillard and Dreman both accept underperformance as the price of avoiding fashion. Eveillard's margin of safety is more explicitly accounting-defensive and cash/gold aware, making him a useful contrast to Dreman's 2008 financial-stock denominator failure.

Most opposite: William J. O'Neil. O'Neil wants earnings acceleration, price-volume leadership, and quick loss cutting; Dreman wants low expectations, mean reversion, and patience. Both are systematic educators, but they look for opposite evidence.

Most opposite: Cathie Wood. Wood underwrites long-duration disruptive growth and accepts high valuation when five-year optionality is large. Dreman distrusts high-expectation narratives and prefers already-discounted bad news.

Most opposite on payoff shape: Mark Spitznagel and Nassim Nicholas Taleb. Dreman absorbs recurring mark-to-market discomfort for mean reversion in cheap equities. Spitznagel/Taleb pay carry for convex crisis protection and worry that ordinary-looking value bets can hide ruin risk.

Unresolved Questions

1. The clean personal track record remains unavailable. The best public evidence covers fund share classes, DVM composites, related variable products, separate accounts, and firm AUM. It does not produce a complete David Dreman personal-account ledger.

2. AUM decline decomposition is still approximate. The 2007-2009 drop combines market losses, redemptions, sponsor changes, product closures, and possible strategy/client mix changes. Public sources do not fully separate those drivers.

3. The complete 2008 exposure path needs more quarter-by-quarter reconstruction. The March 2008 13F is useful but not a complete portfolio, not a short/derivatives ledger, not non-U.S. exposure, and not necessarily representative of every fund.

4. Post-crisis process changes are only partly visible. Interviews and fund documents indicate a harder rule around companies with no or indeterminate earnings, but the degree to which DVM changed bank/financial underwriting after 2008 remains thinly documented.

5. Current personal status is bounded, not fully proved. The profile found 2025 corporate/university evidence and no targeted obituary result through 2026-07-25, while IAPD/ADV documents the firm/regulatory boundary. That is enough for a public-research status note, not a vital-record conclusion (SEC/IAPD firm summary; 2018 ADV; UM Today 2025).

Started for Task A on 2026-07-20. Ranked by usefulness for the profile; dates, vehicle boundaries and measurement caveats in the annotations are part of the evidence.

Task A — Profile

1. University of Manitoba — honorary-degree citation — Best institutional biography: 1936 Winnipeg birth, family, verified 1957 B.Comm., early career, entity chronology, 1999 LL.D. and dated AUM.
2. Dreman Value Management 2018 Form ADV — Latest full regulatory filing located: ownership, titles, staffing, clients, $156.766 million AUM, signature and empty disclosure-reporting pages.
3. SEC/IAPD — Dreman Value Management firm summary — Current official registration boundary: not registered/reporting; SEC registration terminated 2018-06-29.
4. Florida Division of Corporations — 2025 annual report — Current official corporate filing signed in Dreman’s name as manager on 2025-04-17; strongest located living-status evidence, but not a vital record.
5. Scudder-Dreman High Return Equity 2003 audited annual report — Primary share-class returns, benchmarks, loads, rankings, fees and auditor opinion; anchors the strong ten-year record and its caveats.
6. SEC — 2007 fund adviser filing — Investment-career start, Dreman/Hoover team, flagship inception and $21.6 billion firm AUM at 2006 year-end.
7. SEC — DWS fund-board proxy — Documents approximately $9.0 billion in flagship net assets at 2006 year-end and clarifies sponsor/adviser/subadviser economics.
8. SEC — 2008 plan return filing — Independent public filing reporting flagship Class A’s -45.50% calendar-2008 result beside the plan’s index alternative.
9. New York Times — “Contrarian Fund Manager, Exits Unbowed” — Contemporaneous high-quality account of the flagship mandate termination, Dreman’s defense and financial-stock concentration.
10. DWS Variable Series II 2009 annual report — Primary evidence for the related VIP vehicle’s -48.81% 2008 result and its renaming; useful only with vehicle separation.
11. CBS MoneyWatch — 2009 flagship postmortem — Secondary single-source return reconstruction showing post-scale decay; unrelated fee totals contain apparent unit errors and were rejected.
12. Dreman Value Management — 2010 CIO succession announcement — First-party account of Hoover’s CIO handoff, Dreman’s continuing roles, ownership transfer and product roster.
13. SEC — 2012 multi-manager filing — Regulated evidence for 1977 predecessor date, $4.6 billion 2011 AUM, client allocation and team attribution.
14. SEC — Dreman Contrarian Funds deregistration application — Primary closure evidence: asset transfers, shareholder distributions and requested deregistration in 2013.
15. Dreman Value Management 2014 Form ADV brochure — Dated regulatory description of the firm, Dreman’s chairman role, Hoover/Woodard CIO authority, strategies, conflicts and risk limits.
16. Institutional Investor — “Unexpected Behavior” — Detailed 2007 profile of the $22 billion platform, existing hedge funds, planned long/short suite, staff build-out and strategy rationale.
17. Forbes/GuruFocus — 2015 interview — First-person career recollections, formative losses, low-P/E reasoning and late-career positioning; retrospective and promotional claims require corroboration.
18. UM Today — 2025 lab opening — Current institutional evidence that Dreman funded lab construction and that his behavioral-finance legacy remains active; does not establish his attendance or current academic role.
19. University of Wyoming — 1989 board minutes — Primary evidence for the Lodestar transaction and transfer from DVM Inc. to a new partnership.
20. Dorfman Value Investments — January 2025 archive — Former colleague/mentee’s description of Dreman as “mostly retired”; the page embeds an inconsistent 2024 dateline and is not an official retirement notice.
21. CFA Institute — Dreman and Berry, “Analyst Forecasting Errors” — Publisher abstract and methods summary for the 66,100-estimate study central to Dreman’s critique of precise forecasts.
22. Dreman and Lufkin — “Investor Overreaction” — DOI record for the 2000 paper connecting favored/unfavored stock returns and fundamental changes to psychological overreaction.
23. SEC — 2010 multi-manager filing — Regulated source for approximately $4.7 billion of DVM AUM at 2009 year-end and team attribution.
24. SEC/IAPD — David Dreman individual report — Generated 2026-06-17: not currently registered and no disclosure events; employment data were last updated in 2013 and are not current-role proof.
25. WorldCat — Psychology and the Stock Market — Bibliographic record establishing Dreman's 1977 book title, publisher, pagination and subject classification.

Task B — Investment Philosophy

1. Dreman Value Management — 2014 Form ADV brochure — Best regulated synthesis of the mature team process: behavioral premise, screening funnel, industry-relative valuation, fundamental selection and three-part permanent-loss framework; dated after the CIO handoff.
2. American Skandia Trust — 2006 prospectus — Most detailed pre-crisis regulated checklist located: low P/E first, P/B and P/CF next, declining institutional ownership, liquidity tests, mandate-specific leverage and yield goals, and explicit warning that cheapness alone is insufficient.
3. CFA Institute — Dreman and Berry, “Analyst Forecasting Errors” — Publisher abstract for the 66,100-estimate study underpinning Dreman's rejection of precise earnings forecasts.
4. Dreman and Lufkin — “Investor Overreaction” — Dreman-authored empirical case that return divergence between favored and unfavored stocks was not matched by comparable fundamental divergence; causal interpretation remains contestable.
5. Morningstar — 2012 Dreman interview — Direct evidence for behavioral discipline, low-multiple rules, rejection of gut instinct, 100-stock equal-weight guidance, valuation exits and Dreman's qualified endorsement of indexing.
6. Los Angeles Times — 1996 Dreman interview — Contemporaneous personal account of primary low-P/E selection, rising-earnings filter, market-multiple exit, three-year rule, deterioration exit and difficult holding periods.
7. Motley Fool — 2004 Dreman interview — Direct, unusually detailed sell discipline: staged valuation exit, stale-thesis time limit and immediate exit after materially bad news.
8. Forbes — 2012 Steve Forbes interview — Direct post-crisis account of 50–60-stock construction, market-multiple sales and the new rule to exit loss-reporting companies.
9. Forbes/GuruFocus — 2015 Dreman interview — Late-career first-person discussion of formative error, low-P/E history, bank opacity and the two-to-three-year holding discipline.
10. Sun Capital/Dreman Small Cap Value — 2009 prospectus — Product-specific four-stage workflow: daily rankings, lowest P/E quintile, secondary value screens, bottom-up earnings/dividend research and committee approval.
11. Scudder — 2002 shareholder report — Contemporaneous implementation evidence: purchases after Enron contagion, pharmaceutical additions, actual sector concentrations and named sell activity.
12. Institutional Investor — 2011 post-crisis interview — Strongest direct adverse evidence on hidden bank real-estate exposure, financial concentration, asset loss, persistence and the subsequent rebound claim.
13. New York Times — 2009 flagship removal — Contemporaneous account of Dreman's bank thesis, the failure of the earnings denominator and the sponsor's decision to replace DVM.
14. SEC — 2008 plan return filing — Primary public evidence that the flagship Class A lost 45.50% in calendar 2008; central falsification test for the claimed defensive attributes.
15. Scudder-Dreman — 2003 audited shareholder report — Primary implementation check: top-ten and single-name weights, sector concentrations, bottom-up construction language and historical turnover show that later equal-weight guidance did not describe every actual portfolio.
16. Simon & Schuster — Contrarian Investment Strategies: The Psychological Edge — Official 2012 edition and publisher summary of Dreman's post-crisis argument about psychology, efficient markets, volatility and risk.
17. Tim Loughran — 2012 book review — Independent academic synopsis of the revised book, including leverage and liquidity in three crises, industry-relative selection, diversification logic and rejection of complex products.
18. CFA Institute — 1998 book review — Contemporary professional summary confirming the 1998 book's value research, bias analysis and stock-selection criteria.
19. Dreman — “Overreaction, Underreaction, and the Low-P/E Effect” — Dreman's direct empirical statement of asymmetric reactions to earnings surprises in high- and low-P/E stocks.
20. Lakonishok, Shleifer and Vishny — “Contrarian Investment, Extrapolation, and Risk” — Independent behavioral account supporting extrapolation as a source of value returns rather than greater fundamental risk.
21. Lu Zhang — “The Value Premium” — Important contrary model: value firms can be riskier in bad states, challenging a purely psychological interpretation of the premium.
22. Google Books — Contrarian Investment Strategy — Bibliographic record for the first strategy book, cataloged as a 1979 Random House publication; later DVM materials use 1980, so the discrepancy is preserved rather than silently normalized.
23. GuruFocus — 2010 Dreman interview — Direct post-crisis evidence that the core strategy persisted but the falsification rule changed: earnings that became indeterminate should trigger faster exit.
24. Institutional Investor — 2007 DVM profile — Documents pre-crisis institutional scale, staff build-out and proposed extension of the behavioral thesis into long/short products.
25. Dreman Value Management — 2010 CIO succession announcement — Establishes the founder/team boundary when Hoover became sole CIO in 2010; the 2014 ADV separately documents Woodard's 2013 return as co-CIO.

Task C — Greatest Trades

Added 2026-07-20. Ranked for transaction evidence. Audited fund reports establish holdings and accounting data but their investment commentary remains manager-authored; firmwide DVM positions, related variable portfolios and the flagship are not interchangeable.

1. Scudder-Dreman High Return Equity — 2003 audited annual report — Central primary source: holdings, weights, Humana's realized-gain table, JPMorgan's completed exit, Altria litigation path, and Best Buy/Home Depot profit-taking.
2. Scudder-Dreman High Return Equity — 2004 audited annual report — Primary evidence for UST pricing power, Reynolds reduction, Transocean's top-performer status, energy weights and year-end positions.
3. Scudder-Dreman High Return Equity — 2005 audited annual report — Primary bridge for Reynolds, Transocean and Kerr-McGee realization; confirms Best Buy and Humana were absent by fiscal year-end.
4. DWS Dreman High Return Equity — 2006 audited annual report — Completion source: Reynolds sold at a manager-described significant profit; Transocean and Kerr-McGee no longer held.
5. Scudder-Dreman High Return Equity — 2002 audited annual report — Entry-period holdings and weights for Best Buy, JPMorgan and Kerr-McGee; confirms the post-9/11 tactical basket was gone by November 2002.
6. Scudder-Dreman High Return Equity — 2003 semiannual report — Mid-campaign share counts and marks for Best Buy and JPMorgan, useful for explicitly labeled security-price comparisons.
7. DWS Dreman High Return Equity — 2008 audited annual report — Primary late-stage UST holding and takeover commentary; also confirms Altria remained open after the PMI separation.
8. DWS Dreman High Return Equity — 2007 audited annual report — Audited UST share count, market value and weight before the announced takeover.
9. Kemper-Dreman High Return Equity — 2001 audited annual report — Primary holdings and sizing for the post-9/11 American Express/casino basket.
10. Kemper-Dreman High Return Equity — 2000 audited annual report — Earliest flagship tobacco exposure used; supports long chronology for R.J. Reynolds rather than a 2003 start.
11. Institutional Investor — 2011 Dreman/Hoover profile — Best disclosed completed-trade arithmetic: Ryanair average purchase, special dividend, sale price and DVM/team attribution.
12. Washington Post/Bloomberg — 2005 Altria profile — Contemporaneous independent account of DVM's 2000 first purchase, more-than-doubling, concentration and litigation work.
13. Wall Street Journal syndicated report — 2005 Altria holdings — Firmwide share count, trim and approximately $300 million paper-value increase; not audited realized P&L and not a flagship series.
14. Dreman in Forbes — “Tunnel Vision” — Contemporaneous first-person Altria sum-of-parts and sub-five-times tobacco-component valuation thesis.
15. US Department of Justice — United States v. Philip Morris petition — Primary legal chronology for the February 2005 appellate decision disallowing the requested disgorgement remedy.
16. Los Angeles Times — Florida tobacco-verdict dismissal — Independent contemporaneous corroboration for a key Altria/Reynolds litigation catalyst.
17. Federal Trade Commission — RJR/Brown & Williamson decision — Primary merger-regulatory endpoint for the Reynolds campaign.
18. Altria — UST acquisition closing — Issuer-filed January 2009 cash-price endpoint; it does not prove the fund held every remaining share through closing.
19. Kerr-McGee — 2005 annual report — Issuer evidence for the $85 self-tender, 46.7 million shares purchased and approximate $4 billion outlay.
20. Anadarko — Kerr-McGee acquisition completion — Primary terminal corporate-action source: $70.50 post-split cash consideration and August 2006 closing.
21. Humana — 2003 Form 10-K — Issuer corroboration for the operating-cost, premium-pricing and earnings-improvement thesis; not transaction evidence.
22. Los Angeles Times — 1998 Humana purchase context — Contemporaneous Dreman/firm-level entry evidence; does not establish the flagship's tax-lot date.
23. JPMorgan Chase — 2003 annual report — Issuer corroboration for falling telecom/utilities/media exposure and credit-cost normalization.
24. US Department of Justice — 2022 tobacco-litigation resolution — Current official endpoint for the historic federal RICO case; the later corrective-statements order is not credited to the 2005 trade result.
25. Washington Post — 2001 post-9/11 profile — Contemporaneous account of selling Tenet to fund American Express/casino purchases and of the initial market-price rebound.

Task D — Mistakes and Losses

Added 2026-07-20. Ranked for loss evidence and first-person postmortems. Fund returns, related-vehicle returns, firmwide AUM, security-price changes and personal wealth are separate ledgers; disputed magnitudes are retained only with explicit labels.

1. DWS Dreman High Return Equity — 2008 audited annual report — Primary fiscal-year Class A and Class S returns, fundwide operations, NAV and net-asset evidence; fiscal and calendar observations are not interchangeable.
2. SEC — public plan comparison filing — Primary regulated table reporting the flagship's Class A return of -45.50% in calendar 2008.
3. Institutional Investor — 2011 Dreman postmortem — Best direct retrospective account of hidden bank exposure, persistence, the mandate loss, firm AUM contraction and a separate fund's rebound.
4. Money — “A Star Manager Is Fired” — Contemporaneous secondary account of 1999–2000 results, named 2008 casualties, the approximate flagship loss and Dreman's immediate admission.
5. New York Times — “Contrarian Fund Manager, Exits Unbowed” — Contemporaneous high-quality account of the bank thesis, broken earnings denominator, financial exposure and sponsor decision.
6. Forbes — DWS replacement report — Reports the fund's scale, DWS's long-term-performance rationale and 7.4% exposure to four institutions that entered failure or rescue.
7. SEC — DWS VIP prospectus supplement — Primary confirmation that DVM was replaced on the related VIP portfolio effective June 1, 2009; not evidence that it was the flagship.
8. DWS Variable Series II — 2009 annual report — Primary evidence for the related VIP portfolio's -48.81% calendar-2008 return and renaming, kept separate from flagship results.
9. GuruFocus — 2010 Dreman interview — Direct post-crisis evidence on CDO opacity and the new faster-exit rule when earnings become indeterminate.
10. Forbes — 2012 Steve Forbes interview — Direct evidence for selling loss-reporting companies, reducing financial exposure and widening diversification.
11. Los Angeles Times — 1996 Dreman interview — First-person evidence for the 1968 style drift, the 1990 bank episode, pre-crisis sell rules and Dreman's long familiarity with Fannie and Freddie.
12. GuruFocus — 2015 Dreman interview — Dreman says the go-go reversal hurt but left him with money and discloses an unquantified oil-industry error; conflicts with the exact 75% folklore.
13. Morningstar — 2014 Dreman summary — Secondary source for the widely repeated 75% personal-loss figure; retained only as [unverified] against Dreman's less precise direct account.
14. Hedge Fund Alpha — Globe and Mail interview republication — Located attribution for Dreman naming Fannie and Freddie his worst investment; the original was inaccessible and no exact loss ledger was found.
15. Forbes — Dreman's 2003 GSE defense — Contemporaneous evidence that he defended Fannie and Freddie on valuation and history after accounting warnings had emerged.
16. SEC — Fannie Mae litigation release — Primary regulatory chronology and anticipated minimum $11 billion reduction in previously reported net income.
17. SEC — Fannie Mae settlement announcement — Primary confirmation of the 2006 accounting-fraud settlement and historical restatement boundary.
18. Forbes — Dreman's 2008 bank recommendations — Near-contemporaneous first-person evidence that the bank opportunity thesis persisted amid mortgage losses and dilution.
19. Federal Reserve — 2008 commercial-bank performance — Official crisis context for the GSE conservatorships, Washington Mutual failure and Wachovia funding emergency.
20. Motley Fool — 2004 Dreman interview — Direct pre-crisis sell discipline, including immediate exit after materially adverse thesis news; exposes the later execution contradiction.
21. SEC — Dreman fund-complex liquidation filing — Primary evidence that five small funds were approved for liquidation because their asset bases no longer supported rising costs.
22. Institutional Investor — 2007 DVM profile — Documents the pre-crisis $22 billion platform, hiring and planned product expansion; useful franchise-risk context.
23. SEC — 2010 multi-manager filing — Regulated source for approximately $4.7 billion of DVM AUM at 2009 year-end.
24. Dreman Value Management — 2010 succession announcement — First-party boundary for Hoover's sole-CIO appointment and Dreman's continuing chairman and investment-committee roles.
25. Dreman Value Management — 2014 Form ADV brochure — Regulated description of the mature team process, permanent-loss controls, diversification and post-founder decision authority.
26. American Skandia Trust — 2006 prospectus — Pre-crisis regulated implementation checklist, including valuation, fundamentals, leverage and liquidity filters.
27. Dreman Value Management — 2018 Form ADV — Last located filing: approximately $156.8 million regulatory AUM and no reported disciplinary events; not a causal bridge from 2008.
28. SEC/IAPD — Dreman Value Management summary — Current official registration status; termination does not by itself establish regulator compulsion, insolvency or cause.
29. SEC/IAPD — David Dreman individual report — Current generated report showing no disclosure events; employment fields are stale and not present-role proof.
30. Florida Division of Corporations — 2025 annual report — Official filing signed in Dreman's name on April 17, 2025; strongest located recent living-status evidence, but not a 2026 vital record.
31. SEC — DWS 2013 prospectus supplement — Primary evidence that DVM ceased serving three additional DWS value mandates; the filing gives no causal performance explanation.
32. SEC — VALIC 2015 filing — Primary confirmation that VALIC terminated DVM as a small-cap co-subadviser effective December 7, 2015.
33. SEC — American Beacon 2017 prospectus — Primary chronology for DVM's June 2016 replacement by Foundry; the filing does not attribute the decision to 2008.
34. BLS — September 2014 employment report — Primary macro endpoint showing unemployment reached 5.9%, the threshold Dreman attached to his inflation forecast.
35. BLS — September 2014 CPI report — Primary falsification evidence: CPI was up 1.7% year over year, not the forecast 10%–12% rate.
36. DWS Dreman High Return Equity — 2007 audited annual report — Primary pre-crisis net assets and Fannie, Freddie and Washington Mutual exposure used in the derived 8.49% concentration.
37. DWS Dreman High Return Equity — May 2008 semiannual report — Primary six-month portfolio snapshot supporting the six-name 16.36% financial exposure; unaudited and not a transaction ledger.
38. DWS Dreman High Return Equity — August 2008 holdings report — Primary point-in-time share counts supporting the position-expansion arithmetic; purchase dates, costs and realized P&L are not disclosed.
39. DWS Dreman High Return Equity — May 2009 semiannual report — Primary partial-rebound return and net-asset evidence through DVM's last full semiannual period; unaudited.

Task E — Own Words

Added 2026-07-21T19:05:10Z. Ranked for direct quotation provenance and corpus mapping. Quote aggregators were used only as exclusion/watchlist leads; DVM strategy language is labeled as firm or adviser language rather than personal Dreman speech.

1. Wall Street Journal — 1998 online Q&A — Edited direct transcript defining contrarian strategies through low P/E, low price/book, low price/cash-flow and high yield; accessible text is short.
2. Washington Post/Bloomberg — 2001 post-9/11 profile — Direct interview on becoming less defensive after September 11 while avoiding technology.
3. Scudder-Dreman High Return Equity — 2003 audited annual report — SEC-filed Dreman Q&A; source for consensus-is-often-wrong and bottom-up discipline language.
4. Scudder-Dreman High Return Equity — 2004 audited annual report — SEC-filed portfolio review covering Fannie Mae, Marsh & McLennan, AIG and pharmaceuticals.
5. Motley Fool — 2004 interview, Part I — Direct interview excerpt with screens, fundamental filters, overreaction analysis and sell criteria.
6. Motley Fool — 2004 interview, Part II — Direct interview excerpt applying the process to Merck, Altria, energy and financials.
7. Washington Post/Bloomberg — 2005 Altria/GSE interview — Direct interview; best short source for Dreman's litigation-diligence language.
8. The Wall Street Transcript — 2005 Dreman profile — Paywalled excerpt confirming DVM's contrarian-value self-description; too thin for heavy quotation.
9. GuruFocus repost — 2007 Consuelo Mack WealthTrack transcript — Secondary transcript of direct broadcast; label as near-primary because original WealthTrack transcript is unavailable.
10. WealthTrack transcript archive page — Current site notice that older transcripts are no longer available; supports the near-primary label on the GuruFocus repost.
11. GuruFocus repost — 2009 Floyd Norris/New York Times item — Repost source for Dreman's 2009 removal context; prefer original NYT when accessible.
12. GuruFocus/Jacob Wolinsky — 2010 Dreman interview — Direct Q&A on post-crisis process modification, CDO opacity and shunned-asset preference.
13. Dreman Value Management — 2010 CIO succession release — First-party firm release quoting Dreman on the Hoover succession and continuing Dreman roles.
14. Institutional Investor — 2011 post-crisis profile — Best direct adverse/source-critical interview: bank mistake, AUM fall, DWS firing and survivor thesis.
15. Dreman Contrarian Funds — 2011 annual report — SEC-filed DVM team language on real earnings, cash flow, margin of safety and post-crisis positioning.
16. Morningstar — 2012 Dreman interview — Direct edited interview on emotions, indexing, value traps, sell rules, bonds, internet stocks and the bank mistake.
17. Simon & Schuster — 2012 publisher page — Official page for Contrarian Investment Strategies: The Psychological Edge; used for bibliographic index, not quotations.
18. Google Books — Contrarian Investment Strategy — Bibliographic record for the 1979 Random House edition; no page quotation used.
19. Open Library — The New Contrarian Investment Strategy — Bibliographic record for the 1982 revised edition; no page quotation used.
20. Internet Archive — Contrarian Investment Strategies: The Next Generation — Access-restricted 1998 book record; quote-site text was excluded pending page verification.
21. CFA Institute — Dreman/Berry, "Analyst Forecasting Errors" — Publisher page for the 66,100-estimate study central to Dreman's analyst-forecast critique.
22. Dreman/Berry PDF mirror — "Analyst Forecasting Errors" — Readable copy used to verify exact short excerpts and methodology; not first-party hosted.
23. CFA Institute — Dreman/Berry, "Overreaction, Underreaction, and the Low-P/E Effect" — Publisher abstract for the earnings-surprise and low-P/E reversion result.
24. SSRN — Dreman/Lufkin, "Do Contrarian Strategies Work within Industries?" — Abstract source for within-industry relative-value mispricing.
25. ResearchGate — Dreman/Lufkin, "Investor Overreaction" — Author-uploaded full text; used with DOI caution because ResearchGate is not the publisher.
26. ResearchGate — Dreman, "Investor Overreaction and Contrarian Strategies" — Author-uploaded AIMR conference paper; compact statement of the contrarian premise.
27. ResearchGate — Dreman/Johnson/MacGregor/Slovic investor sentiment survey — Coauthored survey paper on 2001 sentiment after steep market declines.
28. ResearchGate — MacGregor/Slovic/Dreman/Berry imagery and affect paper — Coauthored behavioral-finance paper on affective imagery and investment judgment.
29. Taylor & Francis — "Bubbles and the Role of Analysts' Forecasts" — Publisher DOI endpoint for Dreman's 2002 analyst/bubble paper; Scribd copy treated as secondary.
30. Dreman High Opportunity Fund — 2012 summary prospectus — SEC prospectus language for low-P/E, financial strength, management and dividends.
31. Dreman Contrarian Mid Cap Value Fund — 2012 summary prospectus — SEC prospectus language for mid-cap application of intrinsic-value and financial-strength screens.
32. Dreman Domestic Large Cap Over-Reaction Fund — 2012 registration filing — SEC filing used for dividend-yield and quantitative-screening language.
33. Dreman Contrarian International Value Fund — 2012 Lipper award release — Team/Hoover firm language only; not personal Dreman quotation.
34. Morgan Stanley — 2014 Dreman Large Cap Value Equity profile — Strategy/factsheet with DVM process and performance context; not personal speech.
35. DVM 2014 Form ADV brochure — Regulatory brochure for DVM process, personnel and risk framing; institutional language only.
36. Tim Loughran — 2012 review PDF — Independent review of The Psychological Edge; used for index context and not as Dreman quote source.
37. Institute of Behavioral Finance homepage — Useful for institute context but homepage appeared frozen/spam-injected; linked PDFs require independent checks.
38. QuoteFancy Dreman page — Exclusion/watchlist only: quote aggregator with incomplete provenance and Rothschild-paraphrase risk.
39. Goodreads Dreman quotes page — Exclusion/watchlist only: community-added, not verified; no quote used.
40. PictureQuotes Dreman page — Exclusion/watchlist only: provenance too thin for Canon quotation use.
41. AZQuotes Dreman example — Exclusion/watchlist only: gives possible page leads but exact book pages were not verified.
42. LibQuotes Dreman page — Exclusion/watchlist only: useful lead for book passages but no final authority without page checks.
43. DVM 2018 Form ADV / IAPD PDF — Current-status/provenance support used from prior tasks; not part of the own-words quote set.

Task F — Key Writings

Added 2026-07-25T03:51:49Z. Ranked for authorship, bibliographic control and explanatory value. Books and bylined papers are treated as works by Dreman; SEC-filed Q&As are direct/near-primary implementation materials; DVM prospectuses, ADVs, factsheets and releases are labeled firm/team language unless Dreman is named personally.

1. Open Library — Psychology and the Stock Market — Best open bibliographic record for the 1977 AMACOM book: title, publisher, 306 pages, ISBN, LCCN, OCLC and subject classification; no chapter-level content used.
2. University of Toledo — market psychology exhibit — Best accessible secondary description of the 1979 Warner paperback/retitled Psychology and the Stock Market and its "psychology as missing dimension" thesis; used cautiously because it is an exhibit note, not a page scan.
3. Google Books — Contrarian Investment Strategy — Best open record for the 1979 Random House strategy book and partial contents; anchors the catalog date, 302 pages and early chapter map.
4. Internet Archive — Contrarian Investment Strategy — Access-restricted metadata confirming 1979 Random House, first edition, and that the 1982 book is the revised edition.
5. Open Library — The New Contrarian Investment Strategy — Best open record for the 1982 Random House revision, pages, ISBN and revised-edition note; no unverified TOC claims used.
6. CFA Institute — Martin Fridson review of Contrarian Investment Strategies: The Next Generation — Best professional synopsis of the 1998 book: value research, analytical biases and Dreman's contrarian stock-selection criteria.
7. Simon & Schuster — Contrarian Investment Strategies: The Psychological Edge — Official publisher record for the 2012 revised book, 496 pages, ISBN and post-crisis positioning.
8. Google Books — The Psychological Edge contents — Best open table-of-contents evidence for 2012 chapter recommendations and structure.
9. Tim Loughran — 2012 review PDF — Best academic review of the 2012 book; strong on within-industry contrarian strategy, analyst forecast limits, bond/inflation warnings and complex-product caution.
10. CFA Institute — Dreman/Berry, "Analyst Forecasting Errors" — Core Dreman empirical paper; publisher page documents 66,100 consensus estimates, forecast-error findings and valuation implications.
11. CFA Institute — Dreman/Berry, "Overreaction, Underreaction, and the Low-P/E Effect" — Core low-P/E/earnings-surprise paper; publisher abstract supports asymmetric surprise and 19-quarter mean-reversion claims.
12. SSRN — Dreman/Lufkin, "Do Contrarian Strategies Work Within Industries?" — Best open abstract for the within-industry contrarian test; supports the industry-neutral interpretation.
13. PM Research — "Do Contrarian Strategies Work Within Industries?" — Publisher record for the 1997 Journal of Investing article; used for provenance alongside SSRN.
14. Taylor & Francis — Dreman/Lufkin, "Investor Overreaction" — Publisher DOI endpoint for the 2000 psychological-basis paper.
15. ResearchGate — Dreman/Lufkin, "Investor Overreaction" — Author-uploaded full text used only to understand method and ideas; publisher DOI remains preferred citation.
16. ResearchGate — Dreman, "Investor Overreaction and Contrarian Strategies" — Author-uploaded AIMR conference paper; best compact Dreman practitioner synthesis of ratios, bubbles, panics and patience.
17. ResearchGate — MacGregor/Slovic/Dreman/Berry imagery paper — Author-uploaded full text for the affect/imagery evidence linking feelings to investment judgments.
18. ResearchGate — Dreman/Johnson/MacGregor/Slovic sentiment survey — Author-uploaded full text for sticky post-decline investor optimism; used as a behavioral-extension paper.
19. Taylor & Francis — "Bubbles and the Role of Analysts' Forecasts" — Publisher DOI endpoint for Dreman's 2002 analyst/bubble paper; mirrors treated as access leads only.
20. Taylor & Francis — Journal of Behavioral Finance issue page with "Bubble Jr." — Bibliographic source for the 2003 editorial commentary; not used for substantive claims because full text was not recovered.
21. Taylor & Francis — "The Influence of Affect on Investor Decision-Making" — Publisher endpoint for the 2004 affect commentary; used only as an unresolved-corpus item.
22. Los Angeles Times — 1996 Dreman Q&A — Best early accessible process interview: primary low-P/E criterion, rising earnings, psychology, market-P/E sell rule, three-year rule and fundamentals exit.
23. Wall Street Journal — 1998 online Q&A — Edited direct transcript defining contrarian screens; used sparingly because accessible text is short.
24. Motley Fool — 2004 Dreman interview, Part I — Best direct sell-discipline interview: market-multiple exit, stale-thesis exit and thesis-breaking bad-news exit.
25. Motley Fool — 2004 Dreman interview, Part II — Applies the process to Merck, Fannie Mae, Altria, ConocoPhillips and sector controversies; useful for adverse foreshadowing.
26. GuruFocus/Jacob Wolinsky — 2010 Dreman interview — Best immediate post-crisis Q&A; supports the faster exit rule when earnings become indeterminate and provides Forbes/career bibliography context.
27. Morningstar — 2012 Dreman interview — Best companion interview to the 2012 book; covers emotion, analyst forecasts, indexing, equal weighting, sell rules and the bank mistake.
28. GuruFocus repost — "High-Frequency Follies" — Accessible Forbes-column example used to establish late bylined-column continuity, not as a comprehensive Forbes archive.
29. Scudder-Dreman High Return Equity — 2002 annual report — SEC-filed Dreman manager Q&A; implementation evidence for bear-market contrarian additions and high-dividend discipline.
30. Scudder-Dreman High Return Equity — 2003 annual report — Cleanest SEC-filed philosophy statement: consensus often wrong, low P/E/P/B/P/CF, bottom-up selection and residual sector weights.
31. Scudder-Dreman High Return Equity — 2004 annual report — SEC-filed implementation/adverse-foreshadowing source, especially Fannie Mae, AIG, pharma and low-P/E confidence under controversy.
32. Dreman/Claymore Dividend & Income Fund — 2006 semiannual report — Mixed personal/institutional source for closed-end/dividend packaging, leverage and Dreman/Woodard/Delaporte Q&A; useful but not central.
33. Dreman High Opportunity Fund — 2012 summary prospectus — Regulated firm-language source for low P/E, financial strength, management, dividends, intrinsic value and value-risk caveats.
34. Dreman Contrarian Mid Cap Value Fund — 2012 summary prospectus — Regulated mid-cap application of intrinsic-value and financial-strength criteria plus risk caveats.
35. Dreman Domestic Large Cap Over-Reaction Fund — 2012 registration filing — Regulated source for quantitative overreaction process, dividend screen and Dreman ultimate-authority language.
36. DVM 2014 Form ADV brochure — Best regulated mature-process source: team roles, market-cap/sector/industry grouping, valuation elimination, three-to-four candidate funnel, permanent-loss risk framing and Dreman bibliography.
37. DVM CIO succession release — First-party source for post-crisis founder/team boundary: Hoover CIO, Dreman chairman/investment-committee role and quantitative-research role.
38. Institutional Investor — "Unexpected Behavior" — Best pre-crisis independent profile of the $22 billion platform, hedge-fund expansion, shorting extension and succession context.
39. Institutional Investor — 2011 post-crisis profile — Best adverse profile: 35%-45% fund losses, AUM collapse, DWS firing, bank-exposure explanation and persistence.
40. New York Times/GuruFocus repost — 2009 DWS removal — Accessible repost of the contemporaneous NYT account; use original if available and avoid unsupported paywalled details.
41. Money — 2009 Dreman firing article — Contemporaneous style-cycle and DWS-firing context; interpretive, not a primary fund record.
42. CBS MoneyWatch — 2009 flagship postmortem — Independent return/scale postmortem; numerical reconstructions retained as single-source unless tied to SEC reports.
43. Washington Post/Bloomberg — 2005 Dreman profile — Strong near-primary profile of legal-risk discounting around Altria, pharma, energy and GSEs.
44. CFA Institute — Lawrence Brown 1996 alternative perspective — Main scholarly pushback on the Dreman/Berry forecast-error interpretation.
45. CFA Institute — Lawrence Brown 1997 additional evidence — Nuanced follow-up: broadly large errors, but decreasing errors and smaller errors for large/high-coverage firms.
46. Lakonishok/Shleifer/Vishny — "Contrarian Investment, Extrapolation, and Risk" — Best independent behavioral-value comparator; context only, not Dreman-specific evidence.
47. Lu Zhang — "The Value Premium" — Best rational-risk counterweight to a purely psychological value-premium explanation; context only.
48. CXO Advisory — "David Dreman: About Value" — Forecast-grading caveat for public calls; not a fund-performance audit.
49. AAII — Dreman strategy screen — Derivative retail-screen translation of Dreman rules; useful only below primary and professional sources.
50. Validea — David Dreman model portfolio — Derivative strategy implementation and performance model; not Dreman-authored and not evidence of actual DVM returns.

Task G — Mental Models

Added 2026-07-25T07:56:32Z. Ranked for reconstructing Dreman's behavioral heuristics, decision checklist, failure modes and individual-investor transferability. The file distinguishes Dreman-authored ideas, DVM team/process documents, SEC-filed product evidence and third-party model translations.

1. Dreman — “Heuristics in Investor Decision Making” — Best direct source for named behavioral models used in the chapter: heuristics, representativeness, small samples, base rates, regression, availability and input-output matching.
2. CFA Institute — Dreman/Berry, “Analyst Forecasting Errors” — Publisher page for the 66,100-estimate study supporting forecast-error humility and the warning against precise valuation inputs.
3. CFA Institute — Dreman/Berry, “Overreaction, Underreaction, and the Low-P/E Effect” — Publisher abstract for the earnings-surprise/low-P/E evidence used to support mean reversion and expectations arbitrage.
4. Morgan Stanley — Dreman Large Cap Value Equity profile — Mature DVM process document: low-P/E basis, secondary valuation screens, fundamental review, 40–60 holding target, cash range and sell criteria.
5. DVM 2014 Form ADV brochure — Regulated source for team roles, industry/sector grouping, fundamental selection, risk framing and the post-founder institutional boundary.
6. SEC/IAPD — Dreman Value Management firm summary — Current official registration boundary for DVM; supports the mental-model file's caution that the adviser is no longer registered/reporting.
7. Dreman Value Management 2018 Form ADV — Latest full ADV located: Dreman's titles/control, $156.8 million discretionary RAUM and no reported disciplinary pages.
8. SEC — Dreman Domestic Large Cap Over-Reaction Fund registration filing — Product-specific SEC filing for mandate constraints, overreaction process and financial-strength/management/dividend filters.
9. Scudder-Dreman High Return Equity — 2003 audited annual report — SEC-filed implementation evidence for buying after temporary setbacks and litigation fear; used as process support, not a personal ledger.
10. Dreman/Claymore Dividend & Income Fund — 2006 semiannual report — SEC-filed evidence for dividend/income implementation and correlated sector exposures that inform false-diversification risk.
11. DVM 13F — March 2008 holdings — Primary point-in-time firmwide long-U.S.-listed exposure to financials; not a personal Dreman account or complete portfolio.
12. Institutional Investor — 2011 post-crisis profile — Best adverse retrospective on 35%–45% fund losses, bank real-estate exposure, AUM contraction and persistence after the crisis.
13. Money — “A Star Manager Is Fired” — Contemporaneous secondary account of DWS removal, named financial casualties and the reported 46% 2008 flagship loss.
14. Validea — David Dreman strategy model — Explicitly derivative retail-screen translation used only as a transferability/idea-generation comparator, not Dreman-authored evidence.
15. Lakonishok/Shleifer/Vishny — “Contrarian Investment, Extrapolation, and Risk” — Independent behavioral-value comparator supporting extrapolation/mispricing as one explanation for value returns.
16. Lu Zhang — “The Value Premium” — Rational-risk counterweight used to avoid overclaiming that Dreman-style value returns are purely behavioral mispricing.

Task H — Synthesis

Added 2026-07-25T08:15:53Z. Ranked in first-use order for the synthesis. These sources consolidate the A-G corpus while preserving the Dreman-personal versus DVM/team/product boundary, current regulatory-status boundary, and behavioral-value versus risk-premium tension.

1. University of Manitoba — honorary-degree citation — Institutional biography for Winnipeg birth, education, 1999 honorary degree and early career chronology.
2. SEC — 2007 DWS adviser filing — Regulated source for investment-career start, flagship inception, Dreman/Hoover team language and $21.6 billion firm AUM at 2006 year-end.
3. CFA Institute — Dreman/Berry, "Analyst Forecasting Errors" — Publisher source for the 66,100-estimate forecast-error study central to the no-false-precision lesson.
4. Scudder-Dreman High Return Equity — 2003 audited annual report — Primary implementation evidence for holdings, turnover, strategy language, tobacco/health-care/JPMorgan evidence and vehicle boundaries.
5. Institutional Investor — 2011 post-crisis profile — Strongest adverse synthesis source: 35%-45% fund losses, bank exposure, DWS removal, AUM contraction, Ryanair trade arithmetic and persistence after the crisis.
6. CFA Institute — Dreman/Berry, "Overreaction, Underreaction, and the Low-P/E Effect" — Publisher abstract for the earnings-surprise/low-P-E asymmetry that supports expectations arbitrage.
7. SEC — 2008 plan comparison filing — Primary public table reporting the flagship Class A calendar-2008 return of -45.50%.
8. Money — "A Star Manager Is Fired" — Contemporaneous secondary source for DWS removal, named financial casualties, 1999-2000 style-cycle comparison and reported 2008 loss context.
9. Morgan Stanley — Dreman Large Cap Value Equity profile — Mature strategy profile for low-P/E process, secondary screens, target holdings, sector risk, sell rules and performance caveats.
10. DVM 2014 Form ADV brochure — Regulated mature-process and personnel source: behavioral premise, grouping/screening workflow, CIO/team roles, conflicts and permanent-loss framing.
11. SEC — Dreman Domestic Large Cap Over-Reaction Fund registration filing — Product-specific evidence for overreaction mandate, quantitative screens, financial-strength/management/dividend checks and product constraints.
12. DVM 13F — March 2008 holdings — Primary point-in-time firmwide U.S.-listed holdings used to bound financial-stock exposure without treating it as a full portfolio ledger.
13. Dreman — "Heuristics in Investor Decision Making" — Direct behavioral-model source for representativeness, small samples, base rates, regression, availability and input-output matching.
14. GuruFocus/Jacob Wolinsky — 2010 Dreman interview — Post-crisis Q&A source for process persistence and faster exit logic when earnings become indeterminate.
15. DVM — 2010 CIO succession announcement — First-party source for Hoover CIO handoff, Dreman's continuing chairman/investment-committee role and founder/team boundary.
16. Lakonishok/Shleifer/Vishny — "Contrarian Investment, Extrapolation, and Risk" — Independent behavioral-value comparator supporting extrapolation/mispricing as one explanation for value returns.
17. Lu Zhang — "The Value Premium" — Rational-risk counterweight used to avoid overclaiming that Dreman-style returns are purely behavioral mispricing.
18. AQR — "Value and Momentum Everywhere" — Factor-context source for cross-market value/momentum evidence and the need to separate signal durability from implementation pain.
19. Validea — David Dreman model portfolio — Derivative screen translation used only for transferability boundaries, not as Dreman-authored or DVM-return evidence.
20. AAII — Dreman strategy screen — Derivative public-data screen source used as an individual-investor comparator and transferability caveat.
21. Washington Post/Bloomberg — 2005 Altria profile — Strong near-primary profile of DVM's litigation-risk discounting around Altria and related unpopular sectors.
22. US Department of Justice — United States v. Philip Morris petition — Primary legal-context source for a tobacco-litigation catalyst used in the regime-dependence discussion.
23. Altria — UST acquisition closing — Issuer-filed cash-price endpoint for the UST corporate-action case.
24. SEC/IAPD — Dreman Value Management firm summary — Current official registration boundary: DVM is not currently registered and is not filing reports.
25. Dreman Value Management 2018 Form ADV — Latest full ADV located: RAUM, Dreman titles/control and disclosure-reporting boundary.
26. UM Today — 2025 Dreman Behavioural Management Lab — Current institutional evidence that Dreman's behavioral-finance legacy remains active; not a vital-record source.